<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">World J Gastroenterol</journal-id><journal-id journal-id-type="pmc-domain-id">818</journal-id><journal-id journal-id-type="pmc-domain">wjg</journal-id><journal-id journal-id-type="publisher-id">WJG</journal-id><journal-title-group><journal-title>World Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="ppub">1007-9327</issn><issn pub-type="epub">2219-2840</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10011966</article-id><article-id pub-id-type="pmcid-ver">PMC10011966.1</article-id><article-id pub-id-type="pmcaid">10011966</article-id><article-id pub-id-type="pmcaiid">10011966</article-id><article-id pub-id-type="pmid">36925459</article-id><article-id pub-id-type="doi">10.3748/wjg.v29.i8.1289</article-id><article-id pub-id-type="other">jWJG.v29.i8.pg1289</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Early-onset colorectal cancer: A review of current knowledge</article-title><alt-title>Saraiva MR <italic toggle="yes">et al</italic>. EOCRC</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Saraiva</surname><given-names initials="MR">Margarida R</given-names></name><aff>Department of Gastroenterology, Instituto Portugu&#234;s de Oncologia de Lisboa Francisco Gentil, Lisboa 1099-023, Portugal</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rosa</surname><given-names initials="I">Isadora</given-names></name><aff>Department of Gastroenterology, Instituto Portugu&#234;s de Oncologia de Lisboa Francisco Gentil, Lisboa 1099-023, Portugal. <email>isarosa@ipolisboa.min-saude.pt</email></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Claro</surname><given-names initials="I">Isabel</given-names></name><aff>Department of Gastroenterology, Instituto Portugu&#234;s de Oncologia de Lisboa Francisco Gentil, Lisboa 1099-023, Portugal</aff></contrib></contrib-group><author-notes><fn><p>Author contributions: Saraiva MR and Rosa I reviewed the literature and wrote the manuscript; Claro I critically reviewed the manuscript; and all authors approved the final version of the manuscript.</p><p>Corresponding author: Isadora Rosa, PhD, Medical Assistant, Department of Gastroenterology, Instituto Portugu&#234;s de Oncologia de Lisboa Francisco Gentil, Rua Prof Lima Bastos, Lisboa 1099-023, Portugal. <email>isarosa@ipolisboa.min-saude.pt</email></p></fn></author-notes><pub-date pub-type="ppub"><day>28</day><month>2</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>28</day><month>2</month><year>2023</year></pub-date><volume>29</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">431205</issue-id><fpage>1289</fpage><lpage>1303</lpage><history><date date-type="received"><day>19</day><month>11</month><year>2022</year></date><date date-type="rev-recd"><day>18</day><month>12</month><year>2022</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>02</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>15</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-13 17:25:37.880"><day>13</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169;The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="WJG-29-1289.pdf"/><abstract><p>Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Although most prevalent among older people, its incidence above 50 years old has been decreasing globally in the last decades, probably as a result of better screening. Paradoxically, its incidence in patients below 50 years old [early-onset CRC (EO-CRC)] has been increasing, for reasons not yet fully understood. EO-CRC&#8217;s increasing incidence is genre independent but shows racial disparities and has been described to occur worldwide. It follows a birth-cohort effect which probably reflects a change in exposure to CRC risk factors. Its incidence is predicted to double until 2030, which makes EO-CRC a serious public health issue. Both modifiable and non-modifiable risk factors have been identified - some are potential targets for preventive measures. EO-CRC is often diagnosed at advanced stages and histological features associated with poor prognosis have been described. EO-CRC presents some distinctive features: Microsatellite in-stability is common, but another subtype of tumours, both microsatellite and chromosome stable also seems relevant. There are no age-specific treatment protocols and studies on EO-CRC survival rates have shown conflicting data. Due to the higher germline pathological mutations found in EO-CRC patients, an accurate genetic risk evaluation should be performed. In this review, we summarize the current evidence on epidemiological, clinical, histopathological and molecular features of EO-CRC and discuss the contribution of genetics and lifestyle risk factors. We further comment on screening strategies and specific dimensions to consider when dealing with a younger cancer patient.</p></abstract><kwd-group><kwd>Colorectal cancer</kwd><kwd>Early-onset</kwd><kwd>Adenocarcinoma</kwd><kwd>Hereditary</kwd><kwd>Birth-cohort effect</kwd><kwd>Risk factors</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>
<bold>Core Tip: </bold>The incidence of early-onset colorectal cancer (EO-CRC) has been surprisingly increasing worldwide and it has become a public health issue. Its clinical, genetic, molecular and histological characteristics suggest that this may be a distinct entity, with a more aggressive behaviour. However, both genetic and environmental risk factors seem to contribute to this observed epidemiological shift in CRC incidence. More evidence is needed in order to clarify EO-CRC aetiology and to develop screening and management strategies.</p><sec><title>INTRODUCTION</title><p>Colorectal cancer (CRC), the most common gastrointestinal cancer, is the third most common malignancy and the third leading cause of cancer-related death globally[<xref rid="B1" ref-type="bibr">1</xref>]. Once perceived as an elderlies&#8217; disease, CRC incidence among the younger population [early-onset CRC (EO-CRC)] has been gaining more relevance. Recent epidemiological data show that, probably due to interventions on risk factors, screening programs implementation and better treatment[<xref rid="B2" ref-type="bibr">2</xref>], the incidence and mortality of CRC in patients older than 50 have been decreasing for the past decades[<xref rid="B3" ref-type="bibr">3</xref>]. On the contrary, from 1939, when the first case-reports of CRC in the young were published[<xref rid="B4" ref-type="bibr">4</xref>], the incidence of EO-CRC has been increasing and is expected to double by 2030[<xref rid="B5" ref-type="bibr">5</xref>].</p><p>Efforts have been made to characterize EO-CRC, questioning if this is a different entity from CRC in the older. As consensus is lacking, the authors review the existing knowledge, namely epidemiology, risk factors, clinical, molecular and genetic characteristics as well as treatment and overall survival (OS). EO-CRC has become a global health issue and there is a need to raise awareness for it, aiming at lowering the suspicion diagnostic threshold for symptomatic young patients.</p></sec><sec><title>EPIDEMIOLOGY</title><p>CRC belongs to the top 3 of the most prevalent cancers worldwide, representing, in 2020, 10% of the global cancer incidence and 9.4% of all cancer-related deaths[<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B6" ref-type="bibr">6</xref>]. Globally, both CRC incidence and mortality have been decreasing in the last decades[<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B5" ref-type="bibr">5</xref>], which is consistently associated to screening programs implementation, thus allowing the detection and removal of adenomatous polyps and consequently interrupting the adenoma-carcinoma sequence[<xref rid="B7" ref-type="bibr">7</xref>]. In fact, the inflection time point when CRC incidence began to decrease occurred in the 1990s, coincident with the adoption and diffusion of colonoscopy for screening of average-risk CRC patients in several countries[<xref rid="B8" ref-type="bibr">8</xref>].</p><p>CRC incidence follows a heterogeneous geographical distribution. The highest incidences have been reported to occur in China, United States of America and Japan. Studies suggest that Human Development Index (HDI) is positively correlated with CRC incidence[<xref rid="B9" ref-type="bibr">9</xref>], meaning that countries with high HDI have a CRC incidence about 4-folds higher than low HDI countries. Currently, developed countries show a stabilizing or declining incidence rate whereas developing countries have an increasing incidence rate. The later is probably related to the increase in exposure to CRC risk factors[<xref rid="B1" ref-type="bibr">1</xref>], reflecting the adoption of a western lifestyle that accompanies economic transition[<xref rid="B10" ref-type="bibr">10</xref>].</p><p>Current data implies that CRC is going through an epidemiological change. In fact, based on data from the United States Surveillance, Epidemiology, and End Results program, Galloway <italic toggle="yes">et al</italic>[<xref rid="B11" ref-type="bibr">11</xref>] concluded that, although CRC incidence is decreasing by 3.1% per year among people above 50 years old, the incidence of EO-CRC is increasing by 1.4% per year. EO-CRC patients currently account for a percentage that ranges from 0.4% to as high as 35.6% with a median of 7% between the considered reports - such high values should be interpreted carefully as they may reflect institutional biases due to cancer centres that probably receive a high referral of EO-CRC patients[<xref rid="B12" ref-type="bibr">12</xref>]. Undoubtedly, CRC has become an increasingly more common diagnosis in younger patients.</p><p>One problem potentially leading to controversial research results is the lack of an agreed definition of EO-CRC patients. Some authors use a cut-off of 40 years old[<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>], but most reports in the literature apply a 50 years old limit[<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>], this later being consistent with the Amsterdam criteria, that identify patients more likely to have an hereditary predisposition for CRC[<xref rid="B16" ref-type="bibr">16</xref>]; 50 years old also coincides with the starting age of most screening programs in the general risk population.</p><p>Most studies found no significant difference in gender distribution in CRC[<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B17" ref-type="bibr">17</xref>] and the available evidence on EO-CRC prevalence found it to be independent of gender as well[<xref rid="B13" ref-type="bibr">13</xref>]. Racial disparities in EO-CRC incidence have however been described, namely with a higher proportion of Black patients, who also have a worse OS rate[<xref rid="B18" ref-type="bibr">18</xref>] - the same occurs for CRC in general in the United States[<xref rid="B19" ref-type="bibr">19</xref>]. A recent study, that suggested that the EO-CRC incidence has increased in all racial groups, reported the most elevated rise in Non-Hispanic White People. However, the overall incidence of EO-CRC in the United States remains higher for African Americans[<xref rid="B20" ref-type="bibr">20</xref>]. In an Israeli study, racial differences were also found, with the highest EO-CRC incidence in the Arabic population[<xref rid="B21" ref-type="bibr">21</xref>].</p><p>The reasons for the increased incidence of EO-CRC are not fully understood. Some authors suggest that the common use of colonoscopy is responsible for a proportion of the detected CRCs in young adults. This may have happened as a consequence of the diffusion of colonoscopy as a screening method as well as of an increased endoscopic capacity and efficiency, which may have unintentionally lowered the threshold for performing colonoscopy in younger patients[<xref rid="B22" ref-type="bibr">22</xref>].</p><p>Another important factor to consider when reflecting about EO-CRC incidence is the globally described existence of a strong birth-cohort effect. This is considered to occur when age-specific incidence rates vary by generation as a result of changes in people&#8217;s exposure to factors associated to disease risk. This is the opposite concept of period effect, when incidence varies at the same time for all generations[<xref rid="B23" ref-type="bibr">23</xref>].</p><p>A report based on the incidence of CRC in people from 20 European countries, aged 20 to 49 years old and including data from 1990 to 2016, elucidates on this effect. It showed that the CRC incidence for people aged 30-39 years old started to increase exactly 10 years earlier than in the 40-49 years old group and that, although the CRC incidence also increased for 20-29 years old patients, the study period (&gt; 1980) did not cover the time inflection for that group. This suggests that the turning point possibly occurred before 1990. Additionally, the biggest incidence rise occurred in patients 20-39 years[<xref rid="B24" ref-type="bibr">24</xref>], which is consistent with results from an American study[<xref rid="B5" ref-type="bibr">5</xref>].</p><p>This recent rise in EO-CRC has been observed globally. A report including data from 20 European countries found that EO-CRC incidence has raised significantly in 14 of them, in 5 of them was stable and decreased only in Italy[<xref rid="B24" ref-type="bibr">24</xref>]. Another study about EO-CRC incidence among 36 countries from 5 continents reported that EO-CRC incidence was stable in 14 countries, decreased in 3 countries (Austria, Italy and Lithuania) and increased in 19 countries. From these 19 countries, 9 presented an isolated increase in EO-CRC incidence rate - in 5 of them CRC incidence was declining in the older population and in the remaining 4 countries it was stable[<xref rid="B17" ref-type="bibr">17</xref>].</p><p>Additionally, authors concluded that the most rapid increase in EO-CRC happened in countries where incidence rates were already the highest, such as South Korea[<xref rid="B10" ref-type="bibr">10</xref>]. This may be justified by the modernization process that occurred earlier in South Korea in comparison with other Asian countries and the consequently rapid dietary transition that took place following the Korean war[<xref rid="B25" ref-type="bibr">25</xref>]. The obesity increase that has been occurring worldwide, both for adults and children, may also play an important role, particularly because Asian countries have been experiencing some of the largest relative increases in body mass indexes[<xref rid="B26" ref-type="bibr">26</xref>].</p><p>In terms of future predictions, it is expected that the incidence rate for EO-CRC will double by 2030, while in older patients incidence it will probably decline by more than one-third. Meaning that, compared to 2010, when only 4.8% of all colon and 9.5% of all rectal cancers were diagnosed in younger patients, by 2030 they will sum up to 10.9% of all colon and 22.9% of all rectal cancers[<xref rid="B5" ref-type="bibr">5</xref>]. These findings explain why EO-CRC is clearly becoming an important public health issue.</p></sec><sec><title>RISK FACTORS</title><p>CRC is a very heterogeneous disease that results from an interaction between genetic and environmental factors. The majority of CRCs are sporadic (70%), a small proportion of cases are caused by inherited syndromes (5%) and the remaining (25%) have an associated hereditary component, which has not yet been well established and is known as familial CRC[<xref rid="B27" ref-type="bibr">27</xref>]. Based on current knowledge, both modifiable and non-modifiable factors may also contribute to EO-CRC.</p><sec><title>Modifiable risk factors</title><p>There is substantial controversy about results from studies concerning risk factors for CRC, and for EO-CRC in particular, especially concerning preventable risk factors. The majority of data about CRC risk factors is based on older age cohorts&#8217; evidence and mainly represents mid- to late-life exposures. But when it comes to EO-CRC, early-life exposures may have a predominant role[<xref rid="B28" ref-type="bibr">28</xref>].</p><p>One of the most consensual risk factors for CRC is excess body weight. This has been associated with an increased risk for CRC[<xref rid="B29" ref-type="bibr">29</xref>] and has become more relevant since obesity prevalence has increased in the last decades[<xref rid="B30" ref-type="bibr">30</xref>], paralleling the tendency of EO-CRC[<xref rid="B31" ref-type="bibr">31</xref>]. In fact, recent data show that obesity is responsible for a 20% higher risk of EO-CRC[<xref rid="B32" ref-type="bibr">32</xref>].</p><p>Early-age exposures and weight are also suggested to influence CRC risk. A meta-analysis concluded that higher body fatness at an early age is associated with a higher risk of colon cancer in men and women, the same not applying to rectal cancer[<xref rid="B33" ref-type="bibr">33</xref>]. This correlation is probably explained by the effect of proinflammatory cytokines produced by the adipose tissue and by the chronic exposure to hyperinsulinemia and insulin-like growth factor 1 (IGF-I), that may contribute to carcinogenesis[<xref rid="B34" ref-type="bibr">34</xref>].</p><p>Another consistently associated risk factor for CRC is diabetes mellitus, with an increased relative risk of 30%[<xref rid="B35" ref-type="bibr">35</xref>]. In fact, a Swedish study concluded that a diabetic patient reaches the 10-year cumulative risk for CRC that justifies the general screening program 5 years earlier than a non-diabetic patient[<xref rid="B36" ref-type="bibr">36</xref>]. Its impact on EO-CRC has already been proved as well[<xref rid="B37" ref-type="bibr">37</xref>].</p><p>Both alcohol[<xref rid="B38" ref-type="bibr">38</xref>] and tobacco[<xref rid="B39" ref-type="bibr">39</xref>] are independent risk factors for CRC. A recent study also showed their contribution to EO-CRC, particularly when concomitantly present[<xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B41" ref-type="bibr">41</xref>]. The protective role of physical activity has been described in different studies that demonstrated an inverse relationship between physical activity and risk of colon cancer. This probably happens due to decreased inflammation, reduced intestinal transit time, decreased IGF-I levels, reduced hyperinsulinemia and modulated immune function, that come with physical activity[<xref rid="B42" ref-type="bibr">42</xref>].</p><p>Conflicting data exists regarding the role of dyslipidaemia in CRC risk. While some studies suggest a protective one[<xref rid="B43" ref-type="bibr">43</xref>], others associate it to a higher risk[<xref rid="B44" ref-type="bibr">44</xref>]. The association between diet and CRC has been extensively studied. Some of the proposed elements associated to a higher risk of CRC are processed and red meat[<xref rid="B45" ref-type="bibr">45</xref>-<xref rid="B47" ref-type="bibr">47</xref>] and sugar sweetened beverages[<xref rid="B48" ref-type="bibr">48</xref>] - these are believed to influence gut immune response and inflammation[<xref rid="B49" ref-type="bibr">49</xref>]. On the contrary, a diet rich in fiber, dairy, fruits, vegetables[<xref rid="B45" ref-type="bibr">45</xref>], fish, beta-carotene, vitamin C, vitamin E, vitamin D and folate has shown a protective effect[<xref rid="B41" ref-type="bibr">41</xref>,<xref rid="B50" ref-type="bibr">50</xref>].</p><p>Aspirin and nonsteroidal anti-inflammatory drugs also exert a dose-dependent protective effect for CRC, through inhibition of the cyclooxygenase pathway[<xref rid="B51" ref-type="bibr">51</xref>]. Some of these interactions may account for the older onset/EO-CRC findings[<xref rid="B41" ref-type="bibr">41</xref>]. The importance of including fiber in the diet is mainly due to the production of short chain fatty acids during fiber fermentation. These have anti-inflammatory and anti-tumor properties[<xref rid="B52" ref-type="bibr">52</xref>] and their levels are inversely related with CRC occurrence[<xref rid="B53" ref-type="bibr">53</xref>].</p><p>The Western diet, typically rich in red and processed meat and poor in fiber, may be implicated on some of the differences found in incidence among populations[<xref rid="B49" ref-type="bibr">49</xref>]. Currently, the increasing incidence of EO-CRC is mostly observed in high-income economies or countries transitioning to a high-income economy and thus adopting Westernized lifestyle habits such as a western diet, weight excess and less activity level - all these may contribute to the increase in EO-CRC[<xref rid="B10" ref-type="bibr">10</xref>].</p><p>Microbiota has been recently proposed to also play a role in CRC pathogenesis. After comparing the colonic bacterial flora of populations considered to be at high and low risk for CRC[<xref rid="B54" ref-type="bibr">54</xref>], differences in microbiota composition were described - this may be a consequence of dietary habits and could harbour a risk for the development of CRC. Besides diet, the use of antibiotics may also affect the microbiota composition and it has been showed that the use of antibiotics, especially when used repeatedly[<xref rid="B55" ref-type="bibr">55</xref>] or for long periods during early to middle adulthood[<xref rid="B56" ref-type="bibr">56</xref>], is associated with an increased risk of developing CRC. From this point on, further research is needed before a microbiota modifying approach is considered. Current data shows conflicting results on prebiotic and probiotic therapy in CRC patients[<xref rid="B57" ref-type="bibr">57</xref>,<xref rid="B58" ref-type="bibr">58</xref>]. Based on the already mentioned birth-cohort effect, it seems that modifiable risk factors may play an important role in EO-CRC pathogenesis. The majority of the already known modifiable factors for CRC in general are believed to also apply to EO-CRC[<xref rid="B41" ref-type="bibr">41</xref>]. However, conflicting and limited evidence demands more studies.</p></sec><sec><title>Non modifiable risk factors</title><p>The most consensual risk factor for CRC is a positive family history[<xref rid="B17" ref-type="bibr">17</xref>]: First-degree relatives (FDR) have an increased risk of developing CRC, especially when the proband was diagnosed at a younger age. In fact, having a FDR diagnosed under the age of 50 increases the risk of developing CRC by more than three-fold[<xref rid="B59" ref-type="bibr">59</xref>]. This risk is also increased for people with more than one affected relative[<xref rid="B59" ref-type="bibr">59</xref>], and for family history among distant relatives[<xref rid="B60" ref-type="bibr">60</xref>]. Additionally, a history of advanced adenomas or even a family history of any kind of adenomas also increases CRC risk[<xref rid="B61" ref-type="bibr">61</xref>,<xref rid="B62" ref-type="bibr">62</xref>].</p><p>Other known conditions that increase the risk for EO-CRC are Lynch syndrome (LS) and familial adenomatous polyposis, among other hereditary CRC syndromes, with a larger proportion of EO-CRC being hereditary compared with older CRC patients[<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B63" ref-type="bibr">63</xref>] (Figure <xref rid="F1" ref-type="fig">1</xref>). Additional risk of EO-CRC has also been described for patients treated with pelvic radiation at young age[<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B64" ref-type="bibr">64</xref>].</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><p>
<bold>Genetic risk in early-onset colorectal cancer.</bold> HS: Hereditary cancer syndromes; LS: Lynch syndrome; FH: Family history of colorectal cancer; EO-CRC: Early-onset colorectal cancer.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="WJG-29-1289-g001.jpg"/></fig><p>Finally, patients with inflammatory bowel disease (IBD) are also known to be at increased risk for CRC[<xref rid="B54" ref-type="bibr">54</xref>], due to long-term inflammation. The highest risk is associated with extensive long duration colitis and/or a concomitant primary sclerosing cholangitis diagnosis. The association with EO-CRC, especially for ulcerative colitis, has been clearly demonstrated[<xref rid="B15" ref-type="bibr">15</xref>]. </p><p>Conflicting data has been published about the correlation between breast cancer and CRC. Several studies have suggested an increased risk of CRC for patients with breast cancer at younger ages, and this relationship has also been suggested for EO-CRC[<xref rid="B15" ref-type="bibr">15</xref>].</p></sec></sec><sec><title>CLINICAL AND HISTOPATHOLOGICAL CHARACTERISTICS</title><p>Evidence from different studies found some differences between EO-CRC and older patients CRC, concerning clinical presentation, location and histological characteristics, suggesting it might be a distinct entity. Most studies have agreed on the clinical features of EO-CRC, namely on the most common presentation symptoms, with abdominal pain, rectal bleeding, weight loss, anaemia, decreased appetite and change in bowel habits[<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B52" ref-type="bibr">52</xref>,<xref rid="B65" ref-type="bibr">65</xref>], as well as on the more frequent presentation with bowel obstruction[<xref rid="B66" ref-type="bibr">66</xref>]. These common clinical symptoms are in accordance with the most common location of EO-CRC in the left colon, more precisely the rectum and the sigmoid colon, as described in the United States[<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B67" ref-type="bibr">67</xref>-<xref rid="B69" ref-type="bibr">69</xref>]. However, global data regarding location are conflicting.</p><p>A delay in the diagnosis of EO-CRC has been consistently described, with one series showing an average delay of 4[<xref rid="B70" ref-type="bibr">70</xref>] to 6 mo[<xref rid="B71" ref-type="bibr">71</xref>] and even with case-reports of a 2 years delay[<xref rid="B72" ref-type="bibr">72</xref>]. This represents a 1.4-fold increase in time when compared to older patients[<xref rid="B70" ref-type="bibr">70</xref>]. Various reasons can justify this, both doctor and patient related. There is probably both a lower suspicion by the clinicians, hence assuming that the symptomatology is associated to other benign and more common pathology (such as irritable bowel syndrome or haemorrhoids) and consequently not investigating further, and a younger patients&#8217; delay in seeking medical attention, out of fear, denial, absence of information about alert symptoms, difficult access to health care or financial reasons[<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B72" ref-type="bibr">72</xref>,<xref rid="B73" ref-type="bibr">73</xref>].</p><p>Several studies consistently demonstrated that younger patients present more often with stage III or IV disease[<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B66" ref-type="bibr">66</xref>,<xref rid="B74" ref-type="bibr">74</xref>]. In fact, one multicentre retrospective study found that 61.2% of EO-CRC compared to 44.5% of older patients presented metastatic disease at diagnosis[<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B75" ref-type="bibr">75</xref>]. A plausible explanation for this relates to the absence of screening programs for younger patients but it may also be due to aggressive histopathological characteristics of EO-CRC and to its potential genetic basis, that may predispose to accelerated carcinogenesis in young patients. The diagnostic delay in younger patients may also contribute to more advanced disease at EO-CRC diagnosis[<xref rid="B76" ref-type="bibr">76</xref>], although this is not completely explained by the longer time to diagnosis[<xref rid="B70" ref-type="bibr">70</xref>].</p><p>Furthermore, synchronous or metachronous tumours more frequently arise in EO-CRC[<xref rid="B76" ref-type="bibr">76</xref>] but precursor adenomatous lesion are less frequently identified in the EO-CRC groups compared with older ones[<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B52" ref-type="bibr">52</xref>] - this also favours the accelerated carcinogenesis hypothesis. Histological predictors of bad prognosis have also been often found in EO-CRC. Young patients&#8217; tumours more frequently display adverse histologic features compared with older CRC patients, such as mucinous or signet cell differentiation and poorly differentiated tumours[<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B66" ref-type="bibr">66</xref>,<xref rid="B68" ref-type="bibr">68</xref>,<xref rid="B77" ref-type="bibr">77</xref>]; lymphovascular, venous, and perineural invasion have also been described to be more common[<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B66" ref-type="bibr">66</xref>].</p></sec><sec><title>MOLECULAR AND GENETIC FEATURES</title><p>Since the classical sequence adenoma-carcinoma implicated in the carcinogenesis of CRC has been proposed, our understanding of its biology has evolved and currently CRC and particularly EO-CRC is believed to be an heterogenous disease, including cases with a strong hereditary component as well as sporadic disease[<xref rid="B78" ref-type="bibr">78</xref>]. For every CRC patient, a genetic aetiology should be considered, and this is particularly important for EO-CRC patients. In the EO-CRC group, even if we exclude LS (the most common hereditary CRC syndrome) patients, there is still a clear familial component, stronger than for older patients[<xref rid="B78" ref-type="bibr">78</xref>].</p><p>It is estimated that 20%-30% of CRC are associated with a family history of colorectal polyps or cancer, and that up to 3%-5% of CRC are attributed to an identifiable inherited CRC syndrome, such as LS, familial adenomatous polyposis, MUTYH-associated polyposis, juvenile polyposis syndrome, Peutz-Jeghers syndrome or others[<xref rid="B79" ref-type="bibr">79</xref>]. Recent studies concluded that 1 in 5 of EO-CRC cases is attributed to hereditary cancer syndromes[<xref rid="B63" ref-type="bibr">63</xref>], and half of those particularly to LS[<xref rid="B80" ref-type="bibr">80</xref>] (Figure <xref rid="F1" ref-type="fig">1</xref>).</p><p>Observing mutational profiles of left-sided CRCs, EO-CRC patients were found to have higher rates of mutations in genes related to cancer-predisposing syndromes, such as <italic toggle="yes">MSH2 </italic>and <italic toggle="yes">MSH6 </italic>(LS), neurofibromatosis type 1, <italic toggle="yes">PTEN </italic>hamartoma tumours syndrome or Cowden&#8217;s syndrome, tuberous sclerosis complex (<italic toggle="yes">TSC</italic>)<italic toggle="yes">1</italic> and <italic toggle="yes">TSC2</italic>, and <italic toggle="yes">BRCA2 </italic>(hereditary breast and ovarian cancer syndrome)[<xref rid="B81" ref-type="bibr">81</xref>].</p><p>Due to the fact that a larger proportion of EO-CRC seems to be hereditary compared with older patients CRCs, the diagnosis of EO-CRC is currently an indication for referral for genetic evaluation[<xref rid="B82" ref-type="bibr">82</xref>]. Additionally, the variability in clinical presentations and potential for phenotypic overlap in CRC justifies the recommendation for genetic testing using a multigene panel for all individuals with an age below 50 years old[<xref rid="B83" ref-type="bibr">83</xref>]. This next-generation genetic tests identify pathogenic germline variants in 16%-20% of EO-CRC cases, including genes with moderate to high penetrance in cancer syndromes[<xref rid="B63" ref-type="bibr">63</xref>,<xref rid="B80" ref-type="bibr">80</xref>].</p><p>The diagnosis of a hereditary cancer syndrome frequently influences therapeutical options. In fact, it determines the surgical approach (<italic toggle="yes">e.g.,</italic> subtotal colectomy instead of segmental resection), the chemotherapy regimen choice, colonoscopy surveillance intervals, and management of potential extracolonic cancers[<xref rid="B84" ref-type="bibr">84</xref>]. Furthermore, genetic testing is also important to identify relatives that may benefit from anticipation of colonoscopy screening[<xref rid="B85" ref-type="bibr">85</xref>].</p><p>Although germline genetic alterations can be implicated in 20% of individuals with EO-CRC, hereditary syndromes continue to account for only a minority of cases and the majority of EO-CRC are sporadic, in patients with no family history of CRC[<xref rid="B86" ref-type="bibr">86</xref>,<xref rid="B87" ref-type="bibr">87</xref>]. CRC represents a heterogenous group of cancers, although its majority can be divided in a few molecular subtypes, that influence treatment options such as chemotherapy regimens and correlate with cancer survival. Interestingly, current evidence suggests a different proportion of molecular tumour subtypes between older and EO-CRCs[<xref rid="B68" ref-type="bibr">68</xref>,<xref rid="B78" ref-type="bibr">78</xref>,<xref rid="B88" ref-type="bibr">88</xref>,<xref rid="B89" ref-type="bibr">89</xref>].</p><p>CRC usually follows one of the three main molecular subtypes: Chromosomal instability (CIN) or suppressor pathway subtype (80%-85%), CpG island methylator phenotype (CIMP) or serrated pathway (40%) or microsatellite instability (MSI) or mutator pathway subtype (10%-15%). The later is characterized by MSI due to loss of DNA mismatch repair (MMR), occurring both in a sporadic manner or in association with germline alterations in MMR genes (LS), as reviewed in Currais<italic toggle="yes"> et al</italic>[<xref rid="B84" ref-type="bibr">84</xref>]<italic toggle="yes">. </italic>These subtypes are not mutually exclusive and can frequently overlap, with a minority of CRCs exhibiting both microsatellite and chromosome stability (MACS)[<xref rid="B78" ref-type="bibr">78</xref>,<xref rid="B89" ref-type="bibr">89</xref>].</p><p>The currently available studies addressing the molecular profile in EO-CRC have reached conflicting results. Some authors present evidence that EO-CRC tumours present more frequently with MSI (MSI-H)[<xref rid="B81" ref-type="bibr">81</xref>,<xref rid="B90" ref-type="bibr">90</xref>]. MSI tumours in these patients are mostly related to LS[<xref rid="B91" ref-type="bibr">91</xref>] and rarely to inactivation of MLH1 (which commonly occurs in older patients) but are more frequently associated with MSH2 inactivation[<xref rid="B92" ref-type="bibr">92</xref>]. They are associated with a better prognosis than microsatellite stable (MSS) tumours[<xref rid="B93" ref-type="bibr">93</xref>]. Other reports describe that the majority of EO-CRC are rather MSS, lacking DNA repair mechanism abnormalities[<xref rid="B94" ref-type="bibr">94</xref>,<xref rid="B95" ref-type="bibr">95</xref>]. EO-CRC MSS tumours are typically localized in the left colon, rarely associate with other primary neoplasms and have a strong familial component, features that distinguish them from MSS CRC in older patients[<xref rid="B94" ref-type="bibr">94</xref>].</p><p>MMR status has potential therapeutical implications. For example, CRCs exhibiting MMR deficiency typically have poor response to fluorouracil-based adjuvant chemotherapy[<xref rid="B93" ref-type="bibr">93</xref>]. Interestingly, however, patients with MMR-deficient tumours tend to exhibit better OS, attributed to the more immunogenic nature of these tumours[<xref rid="B89" ref-type="bibr">89</xref>]. Additionally, metastatic tumours with MMR deficiency are candidates for immune checkpoint inhibitors[<xref rid="B88" ref-type="bibr">88</xref>].</p><p>The CpG island methylator phenotype, seems to play a modest role in EO-CRC. EO-CRC are frequently CIMP-low except for EO-CRC LS patients, for whom a higher proportion will be CIMP-high, compared to those who develop LS-related CRC later in life[<xref rid="B94" ref-type="bibr">94</xref>]. A more recently described subset of CRC, defined by MACS, because of their diploid DNA content and lack of MMR deficiency, may account for 30% of all sporadic CRCs. These affect younger patients more commonly and have been identified frequently in the left distal colon and rectum. Moreover, this molecular subtype has been associated with poor differentiation, early occurrence of metastasis, disease recurrence and lower survival than patients with MSI or CIN. This can be related to its lack of immune response, opposite to the immunogenic favourable properties of MSI-H CRC[<xref rid="B89" ref-type="bibr">89</xref>]. There is still an incomplete understanding of the molecular profile of MACS. Silla <italic toggle="yes">et al</italic>[<xref rid="B78" ref-type="bibr">78</xref>] reviewed its main features: MACS tumours are usually CIMP-low, are rarely associated with <italic toggle="yes">BRAF</italic> mutations, lack MLH1 expression, and present a different pattern of hypomethylation than MSI and CIN CRC. Some published studies suggest that MACS may be related to familial CRC syndromes, based on observed increased frequency in young patients[<xref rid="B96" ref-type="bibr">96</xref>].</p><p>LINE-1 hypomethylation is another feature implied in EO-CRC and is considered to be a surrogate marker for genome-wide hypomethylation. It is associated with increased CIN[<xref rid="B97" ref-type="bibr">97</xref>]. Evidence shows that the degree of LINE-1 hypomethylation is an independent factor for increased cancer related mortality and overall mortality in CRC[<xref rid="B98" ref-type="bibr">98</xref>]. Antelo <italic toggle="yes">et al</italic>[<xref rid="B91" ref-type="bibr">91</xref>] compared this marker in EO-CRC and older CRC and concluded that the first group presented lower levels of LINE-1 methylation, which suggests a distinct molecular subtype of these tumours. Additional studies are needed in order to confirm this association and properly assess the prognostic value of LINE-1 in young-onset CRC.</p><p>As for the consensus molecular subtypes classification, EO-CRC tumours are more likely to have subtypes CMS1 or CMS2 tumours compared with CMS3 or CMS4 tumours[<xref rid="B68" ref-type="bibr">68</xref>]. From a mutational perspective, despite some conflicting data, the most consensual results show that EO-CRC has lower prevalence of <italic toggle="yes">BRAF</italic> V600, <italic toggle="yes">NRAS</italic>, <italic toggle="yes">KRAS</italic> and <italic toggle="yes">APC</italic> mutations in comparison with late-onset CRC[<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B68" ref-type="bibr">68</xref>].</p><p>In order to rigorously determine if the described characteristics are sufficient to consider EO-CRC as a distinct molecular profile, more and larger trials are needed. In fact, although lifestyle factors and exposure are believed to contribute to the EO-CRC incidence increase, germline and molecular data also provide clues to a different CRC pathogenesis.</p></sec><sec><title>TREATMENT</title><p>EO-CRC does not have specific evidence-based treatment protocols. The subset of EO-CRC patients that present an inherited CRC syndrome, such as LS and polyposis syndromes, should follow their respective guidelines. This is important as the surgical approach is generally more radical and there is a need to manage the risk for other syndrome related malignancies by appropriate screening[<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B99" ref-type="bibr">99</xref>].</p><p>For the majority of the patients, although there are no age specific recommendations, current studies show that different therapeutic strategies are being implemented according to the patient&#8217;s age. Surgery is the main curative treatment for CRC, but for high-risk stage II and stage III there is a role for adjuvant chemotherapy[<xref rid="B100" ref-type="bibr">100</xref>]. When comparing EO-CRC with an older cohort (65-75 years old), various studies have found that more patients with early-stage EO-CRC are treated with adjuvant therapy for stage II and III disease. In fact, stage II low-risk EO-CRC patients receive adjuvant therapy 50% of the time, compared with 19.1% in the older cohort[<xref rid="B101" ref-type="bibr">101</xref>,<xref rid="B102" ref-type="bibr">102</xref>]. Curiously, these regimens were not associated with increased survival in stage I or stage II cancers and offered only marginal benefit in stage III and stage IV diseases[<xref rid="B102" ref-type="bibr">102</xref>].</p><p>Additionally, EO-CRC patients have better chances of receiving surgical treatment either for early-stage or for metastatic disease[<xref rid="B66" ref-type="bibr">66</xref>,<xref rid="B103" ref-type="bibr">103</xref>], of receiving radiotherapy at all disease stages and also of being offered more aggressive adjuvant treatment, including multi-agent chemotherapy[<xref rid="B102" ref-type="bibr">102</xref>]. Another study found that EO-CRC patients with stage I or II were more likely to receive adjuvant or neoadjuvant therapy, compared to older patients[<xref rid="B66" ref-type="bibr">66</xref>].</p><p>These studies may reflect the fewer comorbidities of EO-CRC patients, a better performance status and fewer adverse reactions to systemic treatment leading to a better tolerance to multiagent regimens than the older patients[<xref rid="B66" ref-type="bibr">66</xref>]. However, they may also show a bias towards offering more treatment to younger patients and there is a question of whether they are being victims of overtreatment with no proven benefit. According to current knowledge, equal treatment should be offered to EO-CRC (without a hereditary syndrome). More studies on the putative molecular differences between EO-CRC and older age CRC may in the future bring new molecular treatment targets, allowing specific treatment[<xref rid="B11" ref-type="bibr">11</xref>].</p></sec><sec><title>SURVIVAL</title><p>Some authors, supported by population-based studies, suggest that EO-CRC presents a better survival at every stage[<xref rid="B77" ref-type="bibr">77</xref>,<xref rid="B103" ref-type="bibr">103</xref>] and even that 5 years after curative treatment, EO-CRC survivors present the same main causes of death than the general population[<xref rid="B104" ref-type="bibr">104</xref>]. Other studies demonstrated that, after adjusting for stage, the prognosis is not influenced by CRC age[<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B66" ref-type="bibr">66</xref>], with no difference in stage-specific 5-year disease free survival and OS rates[<xref rid="B66" ref-type="bibr">66</xref>].</p><p>On the contrary, there also reports from single institution studies that showed poor clinical outcomes for EO-CRC and some authors suggest that the worse survival described for EO-CRC is caused by adverse histopathological features[<xref rid="B105" ref-type="bibr">105</xref>,<xref rid="B106" ref-type="bibr">106</xref>]. O&#8217;Connell <italic toggle="yes">et al</italic>[<xref rid="B12" ref-type="bibr">12</xref>]&#8217;s review found the average overall 5-year survival for young patients to be 33.4%, consistent with other reports[<xref rid="B107" ref-type="bibr">107</xref>,<xref rid="B108" ref-type="bibr">108</xref>]. When comparing stage-for-stage survival for younger <italic toggle="yes">vs</italic> older patients with CRC, it seems that young patients with earlier stages have better survival than older patients with the same stage disease. On the contrary, EO-CRC patients with advanced stages do the same or worse than older patients with the same advanced stage. This may justify the described overall lower 5-year survival for EO-CRC because these patients frequently present advanced disease, possibly as a consequence of the delayed diagnosis and/or the more aggressive underlying nature of the disease[<xref rid="B12" ref-type="bibr">12</xref>].</p><p>Regarding advanced and metastatic disease, studies found that EO-CRC patients have a lower progression-free survival although this does not impact the relative risk of death or OS compared with older CRC patients[<xref rid="B109" ref-type="bibr">109</xref>]. As for the mortality rate, although CRC mortality is declining overall and, from 2000 to 2014, CRC death rates decreased by 34% in individuals older than 50 years old, it increased by 13% in EO-CRC patients[<xref rid="B110" ref-type="bibr">110</xref>]. One limitation of the studies is that survival outcomes for EO-CRC are often confounded by the inclusion of hereditary colorectal carcinomas, such as LS related CRCs, that are believed to present a better survival compared with non-syndromic colorectal carcinomas[<xref rid="B111" ref-type="bibr">111</xref>,<xref rid="B112" ref-type="bibr">112</xref>].</p></sec><sec><title>SCREENING</title><p>CRC incidence and mortality for people older than 50 years old have been declining and the main proposed reason for that is the successful implementation of CRC screening, with a possible contribution of a change in lifestyle. Screening programmes have mostly emerged over the past few decades and generically apply to adults starting from 50 to 60 years old[<xref rid="B113" ref-type="bibr">113</xref>]. A recent study shows that from 36 countries from 5 continents, only 4 (Costa Rica, Cyprus, India and Philippines) lack any form of screening programmes[<xref rid="B10" ref-type="bibr">10</xref>]. Additionally, only 4 from the 36 mentioned countries have an earlier age cut-off for screening: Italy, beginning at 44 years; China, Japan and Austria, where it begins at 40 years old[<xref rid="B113" ref-type="bibr">113</xref>].</p><p>On the contrary, prevalence of EO-CRC is increasing. Although one reason for this increase could be over detection through screening, that seems unlikely since screening before age 50 is rare in the general population in most countries[<xref rid="B113" ref-type="bibr">113</xref>]. This was the reality until the most recent publication of the American Cancer Society (ACS) guidelines that, for the first time, recommend starting CRC screening at 45 years old for the standard-risk population. The previous CRC screening recommendations have been based on randomized controlled trials and prospective cohort studies. Since there is a lack of data on screening below 50 years old, this recommendation was a result of simulation modelling analyses of screening outcomes, that showed a favourable balance between benefits of screening from 45 years old with its potential life-years gained and the related burdens[<xref rid="B114" ref-type="bibr">114</xref>].</p><p>Although the absolute risk for EO-CRC is still low, it is expected to increase and the disease burden for younger patients is already substantial and potentially long-term. Additionally, current data show that 40-45 years old adults have the same prevalence of adenomas - CRC precursor lesions[<xref rid="B115" ref-type="bibr">115</xref>] - than adults 50-54.5 years old and people aged 40-49 years old account for 75% of the EO-CRC patients[<xref rid="B116" ref-type="bibr">116</xref>]. This questions the current age threshold and supports the ACS recommendation.</p><p>The debate about lowering the screening age is ongoing, as reviewed in Anderson and Samadder[<xref rid="B117" ref-type="bibr">117</xref>]. Those who are favourable to this approach prioritize the need to control the increase in EO-CRC. A study on screening worldwide, showed that two (Austria and Italy) of the only three countries where EO-CRC has declined have screening programs that begin below 50 years old (Italy at 44 and Austria at 40)[<xref rid="B113" ref-type="bibr">113</xref>]. Curiously, in Austria, the decreasing incidence of EO-CRC has only occurred in the 40 to 49 years age group[<xref rid="B10" ref-type="bibr">10</xref>]. Although another study showed that the same happened in Italy, other described an incidence decrease among the 20-39 years old patients[<xref rid="B24" ref-type="bibr">24</xref>].</p><p>Reasons for opposing the new 45 years old age threshold are diverse. One argument is that studies have shown that the biggest increase rate in EO-CRC was observed for people aged 20 to 39 years old, an age sector still not included in the suggested screening program. Another argument is that, although increasing, the absolute numbers of EO-CRC are still low, not relevant enough for a screening strategy change. Other concerns are related to the risk of augmenting health inequities related to access to health care services as well as for excessive financial health care costs, especially considering most European countries are still struggling to finance the current screening programs or are still in the process of implementing them[<xref rid="B24" ref-type="bibr">24</xref>].</p><p>Other authors suggest waiting for adequate randomized screening studies to test the ACS recent recommendation before adopting it and even question if the screening strategy should be applied to a malignancy whose biological and molecular substrate is not fully understood[<xref rid="B95" ref-type="bibr">95</xref>], which could mean that standard screening methods and prevention may not even be appropriate for it.</p><p>Another small study, based on the evidence that EO-CRC affects predominantly the left side of the colon, suggests a screening strategy with flexible sigmoidoscopy to be applied to people from 40 to 49 years old, as their study group observed that 80% to 83% of those tumours were theoretically within the reach of a flexible sigmoidoscopy[<xref rid="B67" ref-type="bibr">67</xref>]. From a different angle, another important factor when reflecting on EO-CRC diagnosis is that only half of the EO-CRC patients with germline pathogenic mutations reported a CRC diagnosis in a FDR and, consequently, were not eligible for high-risk CRC screening[<xref rid="B63" ref-type="bibr">63</xref>]. This contributes to the recommendation of performing genetic testing in all EO-CRC. Moreover, tumour testing for MSI or immunohistochemistry for MLH1, MSH2, MSH6, and PMS2 is recommended for all EO-CRC patients, even in countries where universal CRC MSI screening is still not implemented[<xref rid="B3" ref-type="bibr">3</xref>].</p><p>Another important aspect is the need to alert the medical community for the increasing incidence of EO-CRC and the consequent need for a rigorous assessment of CRC family risk trough detailed and complete family history in medical records, namely reviewing the familiar history of cancer including first- and second-degree relatives as well as personal and familiar history of advanced polyps[<xref rid="B82" ref-type="bibr">82</xref>]. Such systematic evaluation may be difficult to reliably execute in real world clinical practice, but it allows an appropriate determination of the patient risk for CRC and the identification of high-risk patients who should be offered earlier screening. Additionally, existing genetic risk models can also be employed and help identifying patients that benefit from genetic testing[<xref rid="B118" ref-type="bibr">118</xref>].</p><p>Another debatable option is to offer EO-CRC patients next-generation sequencing technology for genetic germline testing. Multigene panel testing has increased detection of germline mutations[<xref rid="B79" ref-type="bibr">79</xref>] in a feasible and more cost-effective way than single gene testing[<xref rid="B82" ref-type="bibr">82</xref>]. Recently, the National Comprehensive Cancer Network guidelines proposed offering multigene panel testing to all EO-CRC, aiming to increase opportunities for primary and secondary cancer prevention[<xref rid="B83" ref-type="bibr">83</xref>].</p><p>The disadvantage of this approach is that by testing more genes there is a higher risk of finding genetic variants of unknown significance or without a clear management evidence-based guideline[<xref rid="B3" ref-type="bibr">3</xref>]. As so, a multidisciplinary discussion with the active participation of a genetics specialist is recom-mended to appropriately offer and interpret genetic results, hence providing an appropriate counselling to EO-CRC patients and their families[<xref rid="B3" ref-type="bibr">3</xref>].</p></sec><sec><title>SPECIFIC CONSIDERATIONS IN THE YOUNG</title><p>When dealing with younger patients with a malignancy, there are some extra needs that should be remembered and appropriately managed. EO-CRC patients, as older ones, may need to deal with adverse effects of the different treatment modalities. They face a higher rate of sexual dysfunction than the general population and report to be less sexually active after surgery[<xref rid="B119" ref-type="bibr">119</xref>]. Although surgery for CRC does not generally affect fertility[<xref rid="B3" ref-type="bibr">3</xref>], chemotherapy, particularly fluorouracil, may reduce sperm count or cause amenorrhea and radiotherapy may also reduce fertility in both men and women[<xref rid="B120" ref-type="bibr">120</xref>].</p><p>Fertility may play a central concern in the management of EO-CRC patients since they may still be in the reproductive age and have incomplete reproductive plans. As so, patients should be referred to reproductive specialists because options for fertility preservation such as banking of cryopreservation of sperm/oocytes/embryos is recommended prior to gonadotoxic chemotherapy and should be discussed, ahead of starting treatment[<xref rid="B121" ref-type="bibr">121</xref>].</p><p>Other aspect to consider in EO-CRC patients is the possibility of the diagnosis and/or treatment to be coincidental with a pregnancy, especially with the common delay in childbearing age in the developed world. In that scenario, a multidisciplinary approach, weighting the risks and benefits for both the mother and the foetus should be employed. Although studies in pregnant women are missing, it is consensually agreed that the first trimester is the most vital period to avoid, if possible, systemic agents[<xref rid="B122" ref-type="bibr">122</xref>]. Besides fertility, another concern for EO-CRC is to cope with the eventual need for transient or permanent ostomy. The present or past history of an ostomy can contribute to worse sexual function and body image[<xref rid="B123" ref-type="bibr">123</xref>].</p><p>Additionally, EO-CRC patients, especially the ones submitted to multimodality therapy, will live the rest of their lives under the threat or burden of long-term sequelae. Long-term survivors have reported sustained functional deficits and symptoms, such as sexual disfunction, anxiety, worse body image, embarrassment with bowel movements and faecal incontinence[<xref rid="B124" ref-type="bibr">124</xref>], with an impact on their quality of life. Concerning the psychosocial dimension, higher depression and anxiety diagnosis have been described for CRC survivors[<xref rid="B125" ref-type="bibr">125</xref>]. Concordantly, the American Society of Clinical Oncology recom-mends that all cancer survivors should be periodically evaluated for symptoms of depression and anxiety using validated measures and adequately managed, if necessary with the referral for psychological or psychiatric consultation[<xref rid="B126" ref-type="bibr">126</xref>]. All of these afore-mentioned factors contribute to the EO-CRC burden of disease, diminish patients&#8217; quality of life and should be appropriately addressed throughout patients&#8217; life.</p></sec><sec><title>CONCLUSION</title><p>By 2030, previsions are that more than 1 in 10 colon cancers and 1 in 4 rectal cancers will be diagnosed in patients younger than 50 years old[<xref rid="B5" ref-type="bibr">5</xref>]. These numbers are alarming and, consequently, as EO-CRC incidence increases, many studies have tried to shed light on this entity, especially comparing it to the traditional older patient CRC. Evidence suggests that EO-CRC differs from older-onset CRC in its clinical characteristics, pathological features, aggressive behaviour, and molecular profiles. These may be responsible for different responses to treatment and survival, although further studies are needed.</p><p>Although a higher proportion of cases, comparing to older patients, is genetic or familial, the majority of EO-CRC cases is still probably related to somatic genetic mutations or epigenetic alterations induced by modifiable risk factors. This is consistent with the birth-cohort effect observed. The contribution of lifestyle risk factors stands as an opportunity for implementing primary prevention measures for CRC, such as the practice of physical activity, having a healthy diet, quitting smoking and limiting alcohol consumption, also preventing obesity and diabetes. A study showed that risk factor modification could diminish CRC-related mortality in about 12% over 20-years[<xref rid="B2" ref-type="bibr">2</xref>].</p><p>This paper also aims at raising awareness of all the clinicians for the need to lower the suspicion threshold for young patients presenting with alarming gastrointestinal symptoms. We also stress the need to obtain complete clinical information, such as history of polyps, familial history (first- and second-degree relatives) and personal diseases history, namely previous radiation therapy or IBD. Only with this information can the genetic risk of EO-CRC be properly evaluated and subsequent genetic consultation be asked for, when indicated.</p><p>EO-CRC patients have some peculiarities and clinicians should be conscious of them. Financial burden and treatment sequelae such as sexual dysfunction, incontinence, anxiety and depression must be considered and managed. Patient&#8217;s reproductive plans should also be discussed. To conclude, although currently we already have some important data about EO-CRC, larger studies with longer follow-up of these patients are needed in order to reach consensus about the nature and pathogenesis of this disease.</p><p>Namely, ongoing studies and clinical trials, by our group and several others across the world, on the impact on survival of increasing clinician awareness on EO-CRC, on the definition of potentially specific phenotypes of EO-CRC, or on their specific responses to radio-, chemo- or immunotherapy will shed light on the subject. Hopefully, by improving young patients&#8217; diagnosis, diminishing its observed delay, tailoring its treatment and follow-up and implementing modifications in lifestyle risk factors, in the future EO-CRC incidence will follow CRC incidence pattern and both entities&#8217; burden will decrease.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.</p></fn><fn><p>Provenance and peer review: Invited article; Externally peer reviewed.</p></fn><fn><p>Peer-review model: Single blind</p></fn><fn><p>Corresponding Author&#8217;s Membership in Professional Societies: American Gastroenterological Association, 1248915.</p></fn><fn><p>Peer-review started: November 19, 2022</p></fn><fn><p>First decision: December 10, 2022</p></fn><fn><p>Article in press: February 158, 2023</p></fn><fn><p>Specialty type: Gastroenterology and hepatology</p></fn><fn><p>Country/Territory of origin: Portugal</p></fn><fn><p>Peer-review report&#8217;s scientific quality classification</p></fn><fn><p>Grade A (Excellent): A</p></fn><fn><p>Grade B (Very good): B</p></fn><fn><p>Grade C (Good): 0</p></fn><fn><p>Grade D (Fair): 0</p></fn><fn><p>Grade E (Poor): 0</p></fn><fn><p>P-Reviewer: Oprea VD, Romania; Mao Y, China S-Editor: Wang JJ L-Editor: A P-Editor: Wang JJ</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>P</given-names></name></person-group><article-title>Global colorectal cancer burden in 2020 and projections to 2040</article-title><source>Transl Oncol</source><year>2021</year><volume>14</volume><fpage>101174</fpage><pub-id pub-id-type="pmid">34243011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tranon.2021.101174</pub-id><pub-id pub-id-type="pmcid">PMC8273208</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogelaar</surname><given-names>I</given-names></name><name name-style="western"><surname>van</surname><given-names>Ballegooijen M</given-names></name><name name-style="western"><surname>Schrag</surname><given-names>D</given-names></name><name name-style="western"><surname>Boer</surname><given-names>R</given-names></name><name name-style="western"><surname>Winawer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Habbema</surname><given-names>JD</given-names></name><name name-style="western"><surname>Zauber</surname><given-names>AG</given-names></name></person-group><article-title>How much can current interventions reduce colorectal cancer mortality in the U.S.?</article-title><source>Cancer</source><year>2006</year><volume>107</volume><fpage>1624</fpage><lpage>1633</lpage><pub-id pub-id-type="pmid">16933324</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.22115</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boardman</surname><given-names>LA</given-names></name><name name-style="western"><surname>Vilar</surname><given-names>E</given-names></name><name name-style="western"><surname>You</surname><given-names>YN</given-names></name><name name-style="western"><surname>Samadder</surname><given-names>J</given-names></name></person-group><article-title>AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management: Expert Review</article-title><source>Clin Gastroenterol Hepatol</source><year>2020</year><volume>18</volume><fpage>2415</fpage><lpage>2424</lpage><pub-id pub-id-type="pmid">32525015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cgh.2020.05.058</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bacon</surname><given-names>HE</given-names></name><name name-style="western"><surname>Sealy</surname><given-names>WB</given-names></name></person-group><article-title>Malignancy of the anus, rectum and sigmoid colon in the young: With report of a case at four and a half years</article-title><source>Am J Surg</source><year>1939</year><volume>45</volume><fpage>339</fpage><lpage>347</lpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bailey</surname><given-names>CE</given-names></name><name name-style="western"><surname>Hu</surname><given-names>CY</given-names></name><name name-style="western"><surname>You</surname><given-names>YN</given-names></name><name name-style="western"><surname>Bednarski</surname><given-names>BK</given-names></name><name name-style="western"><surname>Rodriguez-Bigas</surname><given-names>MA</given-names></name><name name-style="western"><surname>Skibber</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cantor</surname><given-names>SB</given-names></name><name name-style="western"><surname>Chang</surname><given-names>GJ</given-names></name></person-group><article-title>Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010</article-title><source>JAMA Surg</source><year>2015</year><volume>150</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">25372703</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2014.1756</pub-id><pub-id pub-id-type="pmcid">PMC4666003</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name><name name-style="western"><surname>Steliarova-Foucher</surname><given-names>E</given-names></name><name name-style="western"><surname>Lortet-Tieulent</surname><given-names>J</given-names></name><name name-style="western"><surname>Rosso</surname><given-names>S</given-names></name><name name-style="western"><surname>Coebergh</surname><given-names>JW</given-names></name><name name-style="western"><surname>Comber</surname><given-names>H</given-names></name><name name-style="western"><surname>Forman</surname><given-names>D</given-names></name><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name></person-group><article-title>Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012</article-title><source>Eur J Cancer</source><year>2013</year><volume>49</volume><fpage>1374</fpage><lpage>1403</lpage><pub-id pub-id-type="pmid">23485231</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2012.12.027</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pignone</surname><given-names>M</given-names></name><name name-style="western"><surname>Rich</surname><given-names>M</given-names></name><name name-style="western"><surname>Teutsch</surname><given-names>SM</given-names></name><name name-style="western"><surname>Berg</surname><given-names>AO</given-names></name><name name-style="western"><surname>Lohr</surname><given-names>KN</given-names></name></person-group><article-title>Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force</article-title><source>Ann Intern Med</source><year>2002</year><volume>137</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">12118972</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/0003-4819-137-2-200207160-00015</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>CC</given-names></name><name name-style="western"><surname>Sandler</surname><given-names>RS</given-names></name><name name-style="western"><surname>Sanoff</surname><given-names>HK</given-names></name><name name-style="western"><surname>Yang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Lund</surname><given-names>JL</given-names></name><name name-style="western"><surname>Baron</surname><given-names>JA</given-names></name></person-group><article-title>Decrease in Incidence of Colorectal Cancer Among Individuals&#160;50 Years or Older After Recommendations for&#160;Population-based Screening</article-title><source>Clin Gastroenterol Hepatol</source><year>2017</year><volume>15</volume><fpage>903</fpage><lpage>909.e6</lpage><pub-id pub-id-type="pmid">27609707</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cgh.2016.08.037</pub-id><pub-id pub-id-type="pmcid">PMC5337450</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>M</given-names></name><name name-style="western"><surname>Sierra</surname><given-names>MS</given-names></name><name name-style="western"><surname>Laversanne</surname><given-names>M</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name></person-group><article-title>Global patterns and trends in colorectal cancer incidence and mortality</article-title><source>Gut</source><year>2017</year><volume>66</volume><fpage>683</fpage><lpage>691</lpage><pub-id pub-id-type="pmid">26818619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2015-310912</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Torre</surname><given-names>LA</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>RB</given-names></name><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name><name name-style="western"><surname>Weber</surname><given-names>TK</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Global patterns and trends in colorectal cancer incidence in young adults</article-title><source>Gut</source><year>2019</year><volume>68</volume><fpage>2179</fpage><lpage>2185</lpage><pub-id pub-id-type="pmid">31488504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2019-319511</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galloway</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Burns</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Bear</surname><given-names>H</given-names></name><name name-style="western"><surname>Jarrett</surname><given-names>F</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>P</given-names></name><name name-style="western"><surname>George</surname><given-names>WD</given-names></name></person-group><article-title>Colorectal cancer in young adults</article-title><source>Clin Oncol</source><year>1984</year><volume>10</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">6332703</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Connell</surname><given-names>JB</given-names></name><name name-style="western"><surname>Maggard</surname><given-names>MA</given-names></name><name name-style="western"><surname>Livingston</surname><given-names>EH</given-names></name><name name-style="western"><surname>Yo</surname><given-names>CK</given-names></name></person-group><article-title>Colorectal cancer in the young</article-title><source>Am J Surg</source><year>2004</year><volume>187</volume><fpage>343</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">15006562</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjsurg.2003.12.020</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>DT</given-names></name><name name-style="western"><surname>Pai</surname><given-names>RK</given-names></name><name name-style="western"><surname>Rybicki</surname><given-names>LA</given-names></name><name name-style="western"><surname>Dimaio</surname><given-names>MA</given-names></name><name name-style="western"><surname>Limaye</surname><given-names>M</given-names></name><name name-style="western"><surname>Jayachandran</surname><given-names>P</given-names></name><name name-style="western"><surname>Koong</surname><given-names>AC</given-names></name><name name-style="western"><surname>Kunz</surname><given-names>PA</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>GA</given-names></name><name name-style="western"><surname>Ford</surname><given-names>JM</given-names></name><name name-style="western"><surname>Welton</surname><given-names>M</given-names></name><name name-style="western"><surname>Shelton</surname><given-names>A</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Arber</surname><given-names>DA</given-names></name></person-group><article-title>Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features</article-title><source>Mod Pathol</source><year>2012</year><volume>25</volume><fpage>1128</fpage><lpage>1139</lpage><pub-id pub-id-type="pmid">22481281</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/modpathol.2012.61</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Done</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Fang</surname><given-names>SH</given-names></name></person-group><article-title>Young-onset colorectal cancer: A review</article-title><source>World J Gastrointest Oncol</source><year>2021</year><volume>13</volume><fpage>856</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">34457191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4251/wjgo.v13.i8.856</pub-id><pub-id pub-id-type="pmcid">PMC8371519</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Danial</surname><given-names>D</given-names></name><name name-style="western"><surname>Youssef</surname><given-names>ED</given-names></name><name name-style="western"><surname>Maryam</surname><given-names>BM</given-names></name><name name-style="western"><surname>Mohammad</surname><given-names>A</given-names></name><name name-style="western"><surname>Moein</surname><given-names>BM</given-names></name><name name-style="western"><surname>Liliane</surname><given-names>D</given-names></name></person-group><article-title>Risk Factors of Young-Onset Colorectal Cancer: Analysis of a Large Population-Based Registry</article-title><source>Can J Gastroenterol Hepatol</source><year>2022</year><volume>2022</volume><fpage>3582443</fpage><pub-id pub-id-type="pmid">35223684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/3582443</pub-id><pub-id pub-id-type="pmcid">PMC8866030</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stjepanovic</surname><given-names>N</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>L</given-names></name><name name-style="western"><surname>Carneiro</surname><given-names>F</given-names></name><name name-style="western"><surname>Balaguer</surname><given-names>F</given-names></name><name name-style="western"><surname>Cervantes</surname><given-names>A</given-names></name><name name-style="western"><surname>Balma&#241;a</surname><given-names>J</given-names></name><name name-style="western"><surname>Martinelli</surname><given-names>E</given-names></name></person-group><collab>ESMO Guidelines Committee</collab><article-title>Electronic address: clinicalguidelines@esmo.org. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up&#8224;</article-title><source>Ann Oncol</source><year>2019</year><volume>30</volume><fpage>1558</fpage><lpage>1571</lpage><pub-id pub-id-type="pmid">31378807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/annonc/mdz233</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Jakubowski</surname><given-names>CD</given-names></name><name name-style="western"><surname>Fedewa</surname><given-names>SA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>A</given-names></name><name name-style="western"><surname>Azad</surname><given-names>NS</given-names></name></person-group><article-title>Colorectal Cancer in the Young: Epidemiology, Prevention, Management</article-title><source>Am Soc Clin Oncol Educ Book</source><year>2020</year><volume>40</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/EDBK_279901</pub-id><pub-id pub-id-type="pmid">32315236</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffin</surname><given-names>PM</given-names></name><name name-style="western"><surname>Liff</surname><given-names>JM</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>RS</given-names></name><name name-style="western"><surname>Clark</surname><given-names>WS</given-names></name></person-group><article-title>Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study</article-title><source>Gastroenterology</source><year>1991</year><volume>100</volume><fpage>1033</fpage><lpage>1040</lpage><pub-id pub-id-type="pmid">2001800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0016-5085(91)90279-t</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holowatyj</surname><given-names>AN</given-names></name><name name-style="western"><surname>Ruterbusch</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Rozek</surname><given-names>LS</given-names></name><name name-style="western"><surname>Cote</surname><given-names>ML</given-names></name><name name-style="western"><surname>Stoffel</surname><given-names>EM</given-names></name></person-group><article-title>Racial/Ethnic Disparities in Survival Among Patients With Young-Onset Colorectal Cancer</article-title><source>J Clin Oncol</source><year>2016</year><volume>34</volume><fpage>2148</fpage><lpage>2156</lpage><pub-id pub-id-type="pmid">27138583</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2015.65.0994</pub-id><pub-id pub-id-type="pmcid">PMC4962705</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meester</surname><given-names>RG</given-names></name><name name-style="western"><surname>Doubeni</surname><given-names>CA</given-names></name><name name-style="western"><surname>Lansdorp-Vogelaar</surname><given-names>I</given-names></name><name name-style="western"><surname>Goede</surname><given-names>SL</given-names></name><name name-style="western"><surname>Levin</surname><given-names>TR</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>VP</given-names></name><name name-style="western"><surname>Ballegooijen</surname><given-names>Mv</given-names></name><name name-style="western"><surname>Corley</surname><given-names>DA</given-names></name><name name-style="western"><surname>Zauber</surname><given-names>AG</given-names></name></person-group><article-title>Colorectal cancer deaths attributable to nonuse of screening in the United States</article-title><source>Ann Epidemiol</source><year>2015</year><volume>25</volume><fpage>208</fpage><lpage>213.e1</lpage><pub-id pub-id-type="pmid">25721748</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.annepidem.2014.11.011</pub-id><pub-id pub-id-type="pmcid">PMC4554530</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neufeld</surname><given-names>D</given-names></name><name name-style="western"><surname>Shpitz</surname><given-names>B</given-names></name><name name-style="western"><surname>Bugaev</surname><given-names>N</given-names></name><name name-style="western"><surname>Grankin</surname><given-names>M</given-names></name><name name-style="western"><surname>Bernheim</surname><given-names>J</given-names></name><name name-style="western"><surname>Klein</surname><given-names>E</given-names></name><name name-style="western"><surname>Ziv</surname><given-names>Y</given-names></name></person-group><article-title>Young-age onset of colorectal cancer in Israel</article-title><source>Tech Coloproctol</source><year>2009</year><volume>13</volume><fpage>201</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">19609485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10151-009-0501-7</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>CC</given-names></name><name name-style="western"><surname>Lund</surname><given-names>JL</given-names></name><name name-style="western"><surname>Sandler</surname><given-names>RS</given-names></name></person-group><article-title>Young-Onset Colorectal Cancer: Earlier Diagnoses or Increasing Disease Burden?</article-title><source>Gastroenterology</source><year>2017</year><volume>152</volume><fpage>1809</fpage><lpage>1812.e3</lpage><pub-id pub-id-type="pmid">28461196</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2017.04.030</pub-id><pub-id pub-id-type="pmcid">PMC5646667</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Fedewa</surname><given-names>SA</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>WF</given-names></name><name name-style="western"><surname>Miller</surname><given-names>KD</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>PS</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Colorectal Cancer Incidence Patterns in the United States, 1974-2013</article-title><source>J Natl Cancer Inst</source><year>2017</year><volume>109</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djw322</pub-id><pub-id pub-id-type="pmcid">PMC6059239</pub-id><pub-id pub-id-type="pmid">28376186</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vuik</surname><given-names>FE</given-names></name><name name-style="western"><surname>Nieuwenburg</surname><given-names>SA</given-names></name><name name-style="western"><surname>Bardou</surname><given-names>M</given-names></name><name name-style="western"><surname>Lansdorp-Vogelaar</surname><given-names>I</given-names></name><name name-style="western"><surname>Dinis-Ribeiro</surname><given-names>M</given-names></name><name name-style="western"><surname>Bento</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Zadnik</surname><given-names>V</given-names></name><name name-style="western"><surname>Pellis&#233;</surname><given-names>M</given-names></name><name name-style="western"><surname>Esteban</surname><given-names>L</given-names></name><name name-style="western"><surname>Kaminski</surname><given-names>MF</given-names></name><name name-style="western"><surname>Suchanek</surname><given-names>S</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>O</given-names></name><name name-style="western"><surname>M&#225;jek</surname><given-names>O</given-names></name><name name-style="western"><surname>Leja</surname><given-names>M</given-names></name><name name-style="western"><surname>Kuipers</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Spaander</surname><given-names>MC</given-names></name></person-group><article-title>Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years</article-title><source>Gut</source><year>2019</year><volume>68</volume><fpage>1820</fpage><lpage>1826</lpage><pub-id pub-id-type="pmid">31097539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2018-317592</pub-id><pub-id pub-id-type="pmcid">PMC6839794</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>HK</given-names></name></person-group><article-title>Nutrition policy in South Korea</article-title><source>Asia Pac J Clin Nutr</source><year>2008</year><volume>17 Suppl 1</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">18296374</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>H</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Torre</surname><given-names>LA</given-names></name><name name-style="western"><surname>Pearson-Stuttard</surname><given-names>J</given-names></name><name name-style="western"><surname>Islami</surname><given-names>F</given-names></name><name name-style="western"><surname>Fedewa</surname><given-names>SA</given-names></name><name name-style="western"><surname>Goding</surname><given-names>Sauer A</given-names></name><name name-style="western"><surname>Shuval</surname><given-names>K</given-names></name><name name-style="western"><surname>Gapstur</surname><given-names>SM</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Global patterns in excess body weight and the associated cancer burden</article-title><source>CA Cancer J Clin</source><year>2019</year><volume>69</volume><fpage>88</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">30548482</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21499</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#225;rmol</surname><given-names>I</given-names></name><name name-style="western"><surname>S&#225;nchez-de-Diego</surname><given-names>C</given-names></name><name name-style="western"><surname>Pradilla</surname><given-names>Dieste A</given-names></name><name name-style="western"><surname>Cerrada</surname><given-names>E</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>Yoldi MJ</given-names></name></person-group><article-title>Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms18010197</pub-id><pub-id pub-id-type="pmcid">PMC5297828</pub-id><pub-id pub-id-type="pmid">28106826</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nimptsch</surname><given-names>K</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K</given-names></name></person-group><article-title>Is Timing Important?</article-title><source>Curr Colorectal Cancer Rep</source><year>2018</year><volume>14</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">30140177</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11888-018-0396-7</pub-id><pub-id pub-id-type="pmcid">PMC6101255</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karahalios</surname><given-names>A</given-names></name><name name-style="western"><surname>English</surname><given-names>DR</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>JA</given-names></name></person-group><article-title>Weight change and risk of colorectal cancer: a systematic review and meta-analysis</article-title><source>Am J Epidemiol</source><year>2015</year><volume>181</volume><fpage>832</fpage><lpage>845</lpage><pub-id pub-id-type="pmid">25888582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/kwu357</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Beydoun</surname><given-names>MA</given-names></name><name name-style="western"><surname>Min</surname><given-names>J</given-names></name><name name-style="western"><surname>Xue</surname><given-names>H</given-names></name><name name-style="western"><surname>Kaminsky</surname><given-names>LA</given-names></name><name name-style="western"><surname>Cheskin</surname><given-names>LJ</given-names></name></person-group><article-title>Has the prevalence of overweight, obesity and central obesity levelled off in the United States?</article-title><source>Int J Epidemiol</source><year>2020</year><volume>49</volume><fpage>810</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">32016289</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyz273</pub-id><pub-id pub-id-type="pmcid">PMC7394965</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>P</given-names></name><name name-style="western"><surname>De</surname><given-names>P</given-names></name></person-group><article-title>Trends in colorectal cancer incidence and related lifestyle risk factors in 15-49-year-olds in Canada, 1969-2010</article-title><source>Cancer Epidemiol</source><year>2016</year><volume>42</volume><fpage>90</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">27060626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.canep.2016.03.009</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>PH</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K</given-names></name><name name-style="western"><surname>Ng</surname><given-names>K</given-names></name><name name-style="western"><surname>Zauber</surname><given-names>AG</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>LH</given-names></name><name name-style="western"><surname>Song</surname><given-names>M</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>CS</given-names></name><name name-style="western"><surname>Ogino</surname><given-names>S</given-names></name><name name-style="western"><surname>Willett</surname><given-names>WC</given-names></name><name name-style="western"><surname>Chan</surname><given-names>AT</given-names></name><name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women</article-title><source>JAMA Oncol</source><year>2019</year><volume>5</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">30326010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoncol.2018.4280</pub-id><pub-id pub-id-type="pmcid">PMC6382547</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hidayat</surname><given-names>K</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CM</given-names></name><name name-style="western"><surname>Shi</surname><given-names>BM</given-names></name></person-group><article-title>Body fatness at an early age and risk of colorectal cancer</article-title><source>Int J Cancer</source><year>2018</year><volume>142</volume><fpage>729</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">29023686</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.31100</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van</surname><given-names>Kruijsdijk RC</given-names></name><name name-style="western"><surname>van</surname><given-names>der Wall E</given-names></name><name name-style="western"><surname>Visseren</surname><given-names>FL</given-names></name></person-group><article-title>Obesity and cancer: the role of dysfunctional adipose tissue</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2009</year><volume>18</volume><fpage>2569</fpage><lpage>2578</lpage><pub-id pub-id-type="pmid">19755644</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1055-9965.EPI-09-0372</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Orsini</surname><given-names>N</given-names></name><name name-style="western"><surname>Wolk</surname><given-names>A</given-names></name></person-group><article-title>Diabetes mellitus and risk of colorectal cancer: a meta-analysis</article-title><source>J Natl Cancer Inst</source><year>2005</year><volume>97</volume><fpage>1679</fpage><lpage>1687</lpage><pub-id pub-id-type="pmid">16288121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/dji375</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>Khan U</given-names></name><name name-style="western"><surname>Fallah</surname><given-names>M</given-names></name><name name-style="western"><surname>Sundquist</surname><given-names>K</given-names></name><name name-style="western"><surname>Sundquist</surname><given-names>J</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>H</given-names></name><name name-style="western"><surname>Kharazmi</surname><given-names>E</given-names></name></person-group><article-title>Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study</article-title><source>PLoS Med</source><year>2020</year><volume>17</volume><fpage>e1003431</fpage><pub-id pub-id-type="pmid">33186354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.1003431</pub-id><pub-id pub-id-type="pmcid">PMC7665813</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Fritz</surname><given-names>CDL</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Zong</surname><given-names>X</given-names></name><name name-style="western"><surname>Nickel</surname><given-names>KB</given-names></name><name name-style="western"><surname>Tipping</surname><given-names>A</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>LH</given-names></name><name name-style="western"><surname>Chan</surname><given-names>AT</given-names></name><name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name><name name-style="western"><surname>Colditz</surname><given-names>GA</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>MA</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>PT</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>NO</given-names></name><name name-style="western"><surname>Fields</surname><given-names>RC</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Type 2 Diabetes and Risk of Early-Onset Colorectal Cancer</article-title><source>Gastro Hep Advances</source><year>2022</year><volume>1</volume><fpage>186</fpage><lpage>193</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gastha.2021.10.009</pub-id><pub-id pub-id-type="pmcid">PMC11308819</pub-id><pub-id pub-id-type="pmid">39131121</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McNabb</surname><given-names>S</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>TA</given-names></name><name name-style="western"><surname>Albanes</surname><given-names>D</given-names></name><name name-style="western"><surname>Berndt</surname><given-names>SI</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>H</given-names></name><name name-style="western"><surname>Caan</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>PT</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chang-Claude</surname><given-names>J</given-names></name><name name-style="western"><surname>Chan</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>English</surname><given-names>DR</given-names></name><name name-style="western"><surname>Giles</surname><given-names>GG</given-names></name><name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>RB</given-names></name><name name-style="western"><surname>Hoffmeister</surname><given-names>M</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>AD</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Le</surname><given-names>Marchand L</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>M&#228;nnist&#246;</surname><given-names>S</given-names></name><name name-style="western"><surname>Milne</surname><given-names>RL</given-names></name><name name-style="western"><surname>Nan</surname><given-names>H</given-names></name><name name-style="western"><surname>Newton</surname><given-names>CC</given-names></name><name name-style="western"><surname>Ogino</surname><given-names>S</given-names></name><name name-style="western"><surname>Parfrey</surname><given-names>PS</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>PS</given-names></name><name name-style="western"><surname>Potter</surname><given-names>JD</given-names></name><name name-style="western"><surname>Schoen</surname><given-names>RE</given-names></name><name name-style="western"><surname>Slattery</surname><given-names>ML</given-names></name><name name-style="western"><surname>Su</surname><given-names>YR</given-names></name><name name-style="western"><surname>Tangen</surname><given-names>CM</given-names></name><name name-style="western"><surname>Tucker</surname><given-names>TC</given-names></name><name name-style="western"><surname>Weinstein</surname><given-names>SJ</given-names></name><name name-style="western"><surname>White</surname><given-names>E</given-names></name><name name-style="western"><surname>Wolk</surname><given-names>A</given-names></name><name name-style="western"><surname>Woods</surname><given-names>MO</given-names></name><name name-style="western"><surname>Phipps</surname><given-names>AI</given-names></name><name name-style="western"><surname>Peters</surname><given-names>U</given-names></name></person-group><article-title>Meta-analysis of 16 studies of the association of alcohol with colorectal cancer</article-title><source>Int J Cancer</source><year>2020</year><volume>146</volume><fpage>861</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">31037736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.32377</pub-id><pub-id pub-id-type="pmcid">PMC6819207</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botteri</surname><given-names>E</given-names></name><name name-style="western"><surname>Iodice</surname><given-names>S</given-names></name><name name-style="western"><surname>Bagnardi</surname><given-names>V</given-names></name><name name-style="western"><surname>Raimondi</surname><given-names>S</given-names></name><name name-style="western"><surname>Lowenfels</surname><given-names>AB</given-names></name><name name-style="western"><surname>Maisonneuve</surname><given-names>P</given-names></name></person-group><article-title>Smoking and colorectal cancer: a meta-analysis</article-title><source>JAMA</source><year>2008</year><volume>300</volume><fpage>2765</fpage><lpage>2778</lpage><pub-id pub-id-type="pmid">19088354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2008.839</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zisman</surname><given-names>AL</given-names></name><name name-style="western"><surname>Nickolov</surname><given-names>A</given-names></name><name name-style="western"><surname>Brand</surname><given-names>RE</given-names></name><name name-style="western"><surname>Gorchow</surname><given-names>A</given-names></name><name name-style="western"><surname>Roy</surname><given-names>HK</given-names></name></person-group><article-title>Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">16567601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinte.166.6.629</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosato</surname><given-names>V</given-names></name><name name-style="western"><surname>Bosetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Levi</surname><given-names>F</given-names></name><name name-style="western"><surname>Polesel</surname><given-names>J</given-names></name><name name-style="western"><surname>Zucchetto</surname><given-names>A</given-names></name><name name-style="western"><surname>Negri</surname><given-names>E</given-names></name><name name-style="western"><surname>La</surname><given-names>Vecchia C</given-names></name></person-group><article-title>Risk factors for young-onset colorectal cancer</article-title><source>Cancer Causes Control</source><year>2013</year><volume>24</volume><fpage>335</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">23224326</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10552-012-0119-3</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolin</surname><given-names>KY</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Colditz</surname><given-names>GA</given-names></name><name name-style="western"><surname>Lee</surname><given-names>IM</given-names></name></person-group><article-title>Physical activity and colon cancer prevention: a meta-analysis</article-title><source>Br J Cancer</source><year>2009</year><volume>100</volume><fpage>611</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">19209175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.bjc.6604917</pub-id><pub-id pub-id-type="pmcid">PMC2653744</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kreger</surname><given-names>BE</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>KM</given-names></name><name name-style="western"><surname>Schatzkin</surname><given-names>A</given-names></name><name name-style="western"><surname>Splansky</surname><given-names>GL</given-names></name></person-group><article-title>Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham Study</article-title><source>Cancer</source><year>1992</year><volume>70</volume><fpage>1038</fpage><lpage>1043</lpage><pub-id pub-id-type="pmid">1515981</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0142(19920901)70:5&lt;1038::aid-cncr2820700505&gt;3.0.co;2-m</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>X</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Z</given-names></name></person-group><article-title>Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies</article-title><source>Cancer Causes Control</source><year>2015</year><volume>26</volume><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">25488827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10552-014-0507-y</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vieira</surname><given-names>AR</given-names></name><name name-style="western"><surname>Abar</surname><given-names>L</given-names></name><name name-style="western"><surname>Chan</surname><given-names>DSM</given-names></name><name name-style="western"><surname>Vingeliene</surname><given-names>S</given-names></name><name name-style="western"><surname>Polemiti</surname><given-names>E</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>C</given-names></name><name name-style="western"><surname>Greenwood</surname><given-names>D</given-names></name><name name-style="western"><surname>Norat</surname><given-names>T</given-names></name></person-group><article-title>Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project</article-title><source>Ann Oncol</source><year>2017</year><volume>28</volume><fpage>1788</fpage><lpage>1802</lpage><pub-id pub-id-type="pmid">28407090</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/annonc/mdx171</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parr</surname><given-names>CL</given-names></name><name name-style="western"><surname>Hjart&#229;ker</surname><given-names>A</given-names></name><name name-style="western"><surname>Lund</surname><given-names>E</given-names></name><name name-style="western"><surname>Veier&#248;d</surname><given-names>MB</given-names></name></person-group><article-title>Meat intake, cooking methods and risk of proximal colon, distal colon and rectal cancer: the Norwegian Women and Cancer (NOWAC) cohort study</article-title><source>Int J Cancer</source><year>2013</year><volume>133</volume><fpage>1153</fpage><lpage>1163</lpage><pub-id pub-id-type="pmid">23401013</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.28101</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chao</surname><given-names>A</given-names></name><name name-style="western"><surname>Thun</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Connell</surname><given-names>CJ</given-names></name><name name-style="western"><surname>McCullough</surname><given-names>ML</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Flanders</surname><given-names>WD</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>C</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>R</given-names></name><name name-style="western"><surname>Calle</surname><given-names>EE</given-names></name></person-group><article-title>Meat consumption and risk of colorectal cancer</article-title><source>JAMA</source><year>2005</year><volume>293</volume><fpage>172</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">15644544</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.293.2.172</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuchs</surname><given-names>MA</given-names></name><name name-style="western"><surname>Sato</surname><given-names>K</given-names></name><name name-style="western"><surname>Niedzwiecki</surname><given-names>D</given-names></name><name name-style="western"><surname>Ye</surname><given-names>X</given-names></name><name name-style="western"><surname>Saltz</surname><given-names>LB</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Mowat</surname><given-names>RB</given-names></name><name name-style="western"><surname>Whittom</surname><given-names>R</given-names></name><name name-style="western"><surname>Hantel</surname><given-names>A</given-names></name><name name-style="western"><surname>Benson</surname><given-names>A</given-names></name><name name-style="western"><surname>Atienza</surname><given-names>D</given-names></name><name name-style="western"><surname>Messino</surname><given-names>M</given-names></name><name name-style="western"><surname>Kindler</surname><given-names>H</given-names></name><name name-style="western"><surname>Venook</surname><given-names>A</given-names></name><name name-style="western"><surname>Ogino</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K</given-names></name><name name-style="western"><surname>Willett</surname><given-names>WC</given-names></name><name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name><name name-style="western"><surname>Meyerhardt</surname><given-names>JA</given-names></name></person-group><article-title>Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e99816</fpage><pub-id pub-id-type="pmid">24937507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0099816</pub-id><pub-id pub-id-type="pmcid">PMC4061031</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Keefe</surname><given-names>SJ</given-names></name></person-group><article-title>Diet, microorganisms and their metabolites, and colon cancer</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2016</year><volume>13</volume><fpage>691</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">27848961</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrgastro.2016.165</pub-id><pub-id pub-id-type="pmcid">PMC6312102</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Qin</surname><given-names>H</given-names></name></person-group><article-title>Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies</article-title><source>J Clin Oncol</source><year>2011</year><volume>29</volume><fpage>3775</fpage><lpage>3782</lpage><pub-id pub-id-type="pmid">21876081</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2011.35.7566</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rostom</surname><given-names>A</given-names></name><name name-style="western"><surname>Dub&#233;</surname><given-names>C</given-names></name><name name-style="western"><surname>Lewin</surname><given-names>G</given-names></name><name name-style="western"><surname>Tsertsvadze</surname><given-names>A</given-names></name><name name-style="western"><surname>Barrowman</surname><given-names>N</given-names></name><name name-style="western"><surname>Code</surname><given-names>C</given-names></name><name name-style="western"><surname>Sampson</surname><given-names>M</given-names></name><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name></person-group><collab>U</collab><article-title>S. Preventive Services Task Force. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force</article-title><source>Ann Intern Med</source><year>2007</year><volume>146</volume><fpage>376</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">17339623</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/0003-4819-146-5-200703060-00010</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glover</surname><given-names>M</given-names></name><name name-style="western"><surname>Mansoor</surname><given-names>E</given-names></name><name name-style="western"><surname>Panhwar</surname><given-names>M</given-names></name><name name-style="western"><surname>Parasa</surname><given-names>S</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>GS</given-names></name></person-group><article-title>Epidemiology of Colorectal Cancer in Average Risk Adults 20-39&#160;Years of Age: A Population-Based National Study</article-title><source>Dig Dis Sci</source><year>2019</year><volume>64</volume><fpage>3602</fpage><lpage>3609</lpage><pub-id pub-id-type="pmid">31175493</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10620-019-05690-8</pub-id><pub-id pub-id-type="pmcid">PMC6858534</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>N</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Lu</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Luan</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>F</given-names></name><name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>B</given-names></name></person-group><article-title>Dysbiosis signature of fecal microbiota in colorectal cancer patients</article-title><source>Microb Ecol</source><year>2013</year><volume>66</volume><fpage>462</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">23733170</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00248-013-0245-9</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Annese</surname><given-names>V</given-names></name><name name-style="western"><surname>Beaugerie</surname><given-names>L</given-names></name><name name-style="western"><surname>Egan</surname><given-names>L</given-names></name><name name-style="western"><surname>Biancone</surname><given-names>L</given-names></name><name name-style="western"><surname>Bolling</surname><given-names>C</given-names></name><name name-style="western"><surname>Brandts</surname><given-names>C</given-names></name><name name-style="western"><surname>Dierickx</surname><given-names>D</given-names></name><name name-style="western"><surname>Dummer</surname><given-names>R</given-names></name><name name-style="western"><surname>Fiorino</surname><given-names>G</given-names></name><name name-style="western"><surname>Gornet</surname><given-names>JM</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>P</given-names></name><name name-style="western"><surname>Katsanos</surname><given-names>KH</given-names></name><name name-style="western"><surname>Nissen</surname><given-names>L</given-names></name><name name-style="western"><surname>Pellino</surname><given-names>G</given-names></name><name name-style="western"><surname>Rogler</surname><given-names>G</given-names></name><name name-style="western"><surname>Scaldaferri</surname><given-names>F</given-names></name><name name-style="western"><surname>Szymanska</surname><given-names>E</given-names></name><name name-style="western"><surname>Eliakim</surname><given-names>R</given-names></name></person-group><collab>ECCO</collab><article-title>European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies</article-title><source>J Crohns Colitis</source><year>2015</year><volume>9</volume><fpage>945</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">26294789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ecco-jcc/jjv141</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dik</surname><given-names>VK</given-names></name><name name-style="western"><surname>van</surname><given-names>Oijen MG</given-names></name><name name-style="western"><surname>Smeets</surname><given-names>HM</given-names></name><name name-style="western"><surname>Siersema</surname><given-names>PD</given-names></name></person-group><article-title>Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study</article-title><source>Dig Dis Sci</source><year>2016</year><volume>61</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">26289256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10620-015-3828-0</pub-id><pub-id pub-id-type="pmcid">PMC4700063</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>R</given-names></name><name name-style="western"><surname>Drew</surname><given-names>DA</given-names></name><name name-style="western"><surname>Song</surname><given-names>M</given-names></name><name name-style="western"><surname>Lochhead</surname><given-names>P</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>LH</given-names></name><name name-style="western"><surname>Izard</surname><given-names>J</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>CS</given-names></name><name name-style="western"><surname>Garrett</surname><given-names>WS</given-names></name><name name-style="western"><surname>Huttenhower</surname><given-names>C</given-names></name><name name-style="western"><surname>Ogino</surname><given-names>S</given-names></name><name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name><name name-style="western"><surname>Chan</surname><given-names>AT</given-names></name></person-group><article-title>Long-term use of antibiotics and risk of colorectal adenoma</article-title><source>Gut</source><year>2018</year><volume>67</volume><fpage>672</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">28377387</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2016-313413</pub-id><pub-id pub-id-type="pmcid">PMC5628103</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roller</surname><given-names>M</given-names></name><name name-style="western"><surname>Clune</surname><given-names>Y</given-names></name><name name-style="western"><surname>Collins</surname><given-names>K</given-names></name><name name-style="western"><surname>Rechkemmer</surname><given-names>G</given-names></name><name name-style="western"><surname>Watzl</surname><given-names>B</given-names></name></person-group><article-title>Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients</article-title><source>Br J Nutr</source><year>2007</year><volume>97</volume><fpage>676</fpage><lpage>684</lpage><pub-id pub-id-type="pmid">17349080</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S0007114507450292</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rafter</surname><given-names>J</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>M</given-names></name><name name-style="western"><surname>Caderni</surname><given-names>G</given-names></name><name name-style="western"><surname>Clune</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>R</given-names></name><name name-style="western"><surname>Karlsson</surname><given-names>PC</given-names></name><name name-style="western"><surname>Klinder</surname><given-names>A</given-names></name><name name-style="western"><surname>O'Riordan</surname><given-names>M</given-names></name><name name-style="western"><surname>O'Sullivan</surname><given-names>GC</given-names></name><name name-style="western"><surname>Pool-Zobel</surname><given-names>B</given-names></name><name name-style="western"><surname>Rechkemmer</surname><given-names>G</given-names></name><name name-style="western"><surname>Roller</surname><given-names>M</given-names></name><name name-style="western"><surname>Rowland</surname><given-names>I</given-names></name><name name-style="western"><surname>Salvadori</surname><given-names>M</given-names></name><name name-style="western"><surname>Thijs</surname><given-names>H</given-names></name><name name-style="western"><surname>Van</surname><given-names>Loo J</given-names></name><name name-style="western"><surname>Watzl</surname><given-names>B</given-names></name><name name-style="western"><surname>Collins</surname><given-names>JK</given-names></name></person-group><article-title>Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>85</volume><fpage>488</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">17284748</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajcn/85.2.488</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowery</surname><given-names>JT</given-names></name><name name-style="western"><surname>Ahnen</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Schroy</surname><given-names>PC 3rd</given-names></name><name name-style="western"><surname>Hampel</surname><given-names>H</given-names></name><name name-style="western"><surname>Baxter</surname><given-names>N</given-names></name><name name-style="western"><surname>Boland</surname><given-names>CR</given-names></name><name name-style="western"><surname>Burt</surname><given-names>RW</given-names></name><name name-style="western"><surname>Butterly</surname><given-names>L</given-names></name><name name-style="western"><surname>Doerr</surname><given-names>M</given-names></name><name name-style="western"><surname>Doroshenk</surname><given-names>M</given-names></name><name name-style="western"><surname>Feero</surname><given-names>WG</given-names></name><name name-style="western"><surname>Henrikson</surname><given-names>N</given-names></name><name name-style="western"><surname>Ladabaum</surname><given-names>U</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>D</given-names></name><name name-style="western"><surname>McFarland</surname><given-names>EG</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>SK</given-names></name><name name-style="western"><surname>Raymond</surname><given-names>M</given-names></name><name name-style="western"><surname>Samadder</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Syngal</surname><given-names>S</given-names></name><name name-style="western"><surname>Weber</surname><given-names>TK</given-names></name><name name-style="western"><surname>Zauber</surname><given-names>AG</given-names></name><name name-style="western"><surname>Smith</surname><given-names>R</given-names></name></person-group><article-title>Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review</article-title><source>Cancer</source><year>2016</year><volume>122</volume><fpage>2633</fpage><lpage>2645</lpage><pub-id pub-id-type="pmid">27258162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.30080</pub-id><pub-id pub-id-type="pmcid">PMC5575812</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samadder</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Curtin</surname><given-names>K</given-names></name><name name-style="western"><surname>Tuohy</surname><given-names>TM</given-names></name><name name-style="western"><surname>Rowe</surname><given-names>KG</given-names></name><name name-style="western"><surname>Mineau</surname><given-names>GP</given-names></name><name name-style="western"><surname>Smith</surname><given-names>KR</given-names></name><name name-style="western"><surname>Pimentel</surname><given-names>R</given-names></name><name name-style="western"><surname>Wong</surname><given-names>J</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>K</given-names></name><name name-style="western"><surname>Burt</surname><given-names>RW</given-names></name></person-group><article-title>Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah</article-title><source>Gastroenterology</source><year>2014</year><volume>147</volume><fpage>814</fpage><lpage>821.e5; quiz e15</lpage><pub-id pub-id-type="pmid">25042087</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2014.07.006</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuohy</surname><given-names>TM</given-names></name><name name-style="western"><surname>Rowe</surname><given-names>KG</given-names></name><name name-style="western"><surname>Mineau</surname><given-names>GP</given-names></name><name name-style="western"><surname>Pimentel</surname><given-names>R</given-names></name><name name-style="western"><surname>Burt</surname><given-names>RW</given-names></name><name name-style="western"><surname>Samadder</surname><given-names>NJ</given-names></name></person-group><article-title>Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah</article-title><source>Cancer</source><year>2014</year><volume>120</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">24150925</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.28227</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>SC</given-names></name><name name-style="western"><surname>Lau</surname><given-names>JY</given-names></name><name name-style="western"><surname>Chan</surname><given-names>FK</given-names></name><name name-style="western"><surname>Suen</surname><given-names>BY</given-names></name><name name-style="western"><surname>Tse</surname><given-names>YK</given-names></name><name name-style="western"><surname>Hui</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Leung-Ki</surname><given-names>EL</given-names></name><name name-style="western"><surname>Ching</surname><given-names>JY</given-names></name><name name-style="western"><surname>Chan</surname><given-names>AW</given-names></name><name name-style="western"><surname>Wong</surname><given-names>MC</given-names></name><name name-style="western"><surname>Ng</surname><given-names>SS</given-names></name><name name-style="western"><surname>To</surname><given-names>KF</given-names></name><name name-style="western"><surname>Wu</surname><given-names>JC</given-names></name><name name-style="western"><surname>Sung</surname><given-names>JJ</given-names></name></person-group><article-title>Risk of Advanced Adenomas in Siblings of Individuals With Advanced Adenomas: A Cross-Sectional Study</article-title><source>Gastroenterology</source><year>2016</year><volume>150</volume><fpage>608</fpage><lpage>16; quiz e16</lpage><pub-id pub-id-type="pmid">26584600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2015.11.003</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoffel</surname><given-names>EM</given-names></name><name name-style="western"><surname>Koeppe</surname><given-names>E</given-names></name><name name-style="western"><surname>Everett</surname><given-names>J</given-names></name><name name-style="western"><surname>Ulintz</surname><given-names>P</given-names></name><name name-style="western"><surname>Kiel</surname><given-names>M</given-names></name><name name-style="western"><surname>Osborne</surname><given-names>J</given-names></name><name name-style="western"><surname>Williams</surname><given-names>L</given-names></name><name name-style="western"><surname>Hanson</surname><given-names>K</given-names></name><name name-style="western"><surname>Gruber</surname><given-names>SB</given-names></name><name name-style="western"><surname>Rozek</surname><given-names>LS</given-names></name></person-group><article-title>Germline Genetic Features of Young Individuals With Colorectal&#160;Cancer</article-title><source>Gastroenterology</source><year>2018</year><volume>154</volume><fpage>897</fpage><lpage>905.e1</lpage><pub-id pub-id-type="pmid">29146522</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2017.11.004</pub-id><pub-id pub-id-type="pmcid">PMC5847426</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rombouts</surname><given-names>AJM</given-names></name><name name-style="western"><surname>Hugen</surname><given-names>N</given-names></name><name name-style="western"><surname>Elferink</surname><given-names>MAG</given-names></name><name name-style="western"><surname>Poortmans</surname><given-names>PMP</given-names></name><name name-style="western"><surname>Nagtegaal</surname><given-names>ID</given-names></name><name name-style="western"><surname>de</surname><given-names>Wilt JHW</given-names></name></person-group><article-title>Increased risk for second primary rectal cancer after pelvic radiation therapy</article-title><source>Eur J Cancer</source><year>2020</year><volume>124</volume><fpage>142</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">31765989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2019.10.022</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riaz</surname><given-names>R</given-names></name><name name-style="western"><surname>Masood</surname><given-names>N</given-names></name><name name-style="western"><surname>Benish</surname><given-names>A</given-names></name></person-group><article-title>Red flag symptoms: detailed account of clinicopathological features in young-onset colorectal cancer</article-title><source>Intest Res</source><year>2017</year><volume>15</volume><fpage>203</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">28522950</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5217/ir.2017.15.2.203</pub-id><pub-id pub-id-type="pmcid">PMC5430012</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldvaser</surname><given-names>H</given-names></name><name name-style="western"><surname>Purim</surname><given-names>O</given-names></name><name name-style="western"><surname>Kundel</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shepshelovich</surname><given-names>D</given-names></name><name name-style="western"><surname>Shochat</surname><given-names>T</given-names></name><name name-style="western"><surname>Shemesh-Bar</surname><given-names>L</given-names></name><name name-style="western"><surname>Sulkes</surname><given-names>A</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>B</given-names></name></person-group><article-title>Colorectal cancer in young patients: is it a distinct clinical entity?</article-title><source>Int J Clin Oncol</source><year>2016</year><volume>21</volume><fpage>684</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">26820719</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10147-015-0935-z</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Segev</surname><given-names>L</given-names></name><name name-style="western"><surname>Kalady</surname><given-names>MF</given-names></name><name name-style="western"><surname>Church</surname><given-names>JM</given-names></name></person-group><article-title>Left-Sided Dominance of Early-Onset Colorectal Cancers: A Rationale for Screening Flexible Sigmoidoscopy in the Young</article-title><source>Dis Colon Rectum</source><year>2018</year><volume>61</volume><fpage>897</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">29771800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/DCR.0000000000001062</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willauer</surname><given-names>AN</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>AAL</given-names></name><name name-style="western"><surname>Lam</surname><given-names>M</given-names></name><name name-style="western"><surname>Morris</surname><given-names>JS</given-names></name><name name-style="western"><surname>Raghav</surname><given-names>KPS</given-names></name><name name-style="western"><surname>Morris</surname><given-names>VK</given-names></name><name name-style="western"><surname>Menter</surname><given-names>D</given-names></name><name name-style="western"><surname>Broaddus</surname><given-names>R</given-names></name><name name-style="western"><surname>Meric-Bernstam</surname><given-names>F</given-names></name><name name-style="western"><surname>Hayes-Jordan</surname><given-names>A</given-names></name><name name-style="western"><surname>Huh</surname><given-names>W</given-names></name><name name-style="western"><surname>Overman</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kopetz</surname><given-names>S</given-names></name><name name-style="western"><surname>Loree</surname><given-names>JM</given-names></name></person-group><article-title>Clinical and molecular characterization of early-onset colorectal cancer</article-title><source>Cancer</source><year>2019</year><volume>125</volume><fpage>2002</fpage><lpage>2010</lpage><pub-id pub-id-type="pmid">30854646</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.31994</pub-id><pub-id pub-id-type="pmcid">PMC6583775</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrelli</surname><given-names>F</given-names></name><name name-style="western"><surname>Tomasello</surname><given-names>G</given-names></name><name name-style="western"><surname>Borgonovo</surname><given-names>K</given-names></name><name name-style="western"><surname>Ghidini</surname><given-names>M</given-names></name><name name-style="western"><surname>Turati</surname><given-names>L</given-names></name><name name-style="western"><surname>Dallera</surname><given-names>P</given-names></name><name name-style="western"><surname>Passalacqua</surname><given-names>R</given-names></name><name name-style="western"><surname>Sgroi</surname><given-names>G</given-names></name><name name-style="western"><surname>Barni</surname><given-names>S</given-names></name></person-group><article-title>Prognostic Survival Associated With Left-Sided <italic toggle="yes">vs</italic> Right-Sided Colon Cancer: A Systematic Review and Meta-analysis</article-title><source>JAMA Oncol</source><year>2017</year><volume>3</volume><fpage>211</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">27787550</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoncol.2016.4227</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>FW</given-names></name><name name-style="western"><surname>Sundaram</surname><given-names>V</given-names></name><name name-style="western"><surname>Chew</surname><given-names>TA</given-names></name><name name-style="western"><surname>Ladabaum</surname><given-names>U</given-names></name></person-group><article-title>Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis</article-title><source>Clin Gastroenterol Hepatol</source><year>2017</year><volume>15</volume><fpage>728</fpage><lpage>737.e3</lpage><pub-id pub-id-type="pmid">27856366</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cgh.2016.10.038</pub-id><pub-id pub-id-type="pmcid">PMC5401776</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marble</surname><given-names>K</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name><name name-style="western"><surname>Greenwald</surname><given-names>L</given-names></name></person-group><article-title>Colorectal carcinoma in young patients</article-title><source>J Surg Oncol</source><year>1992</year><volume>51</volume><fpage>179</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">1434643</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jso.2930510311</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Myers</surname><given-names>EA</given-names></name><name name-style="western"><surname>Feingold</surname><given-names>DL</given-names></name><name name-style="western"><surname>Forde</surname><given-names>KA</given-names></name><name name-style="western"><surname>Arnell</surname><given-names>T</given-names></name><name name-style="western"><surname>Jang</surname><given-names>JH</given-names></name><name name-style="western"><surname>Whelan</surname><given-names>RL</given-names></name></person-group><article-title>Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions' experience</article-title><source>World J Gastroenterol</source><year>2013</year><volume>19</volume><fpage>5651</fpage><lpage>5657</lpage><pub-id pub-id-type="pmid">24039357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v19.i34.5651</pub-id><pub-id pub-id-type="pmcid">PMC3769901</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>E</given-names></name><name name-style="western"><surname>Macdonald</surname><given-names>S</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>NC</given-names></name><name name-style="western"><surname>Weller</surname><given-names>D</given-names></name><name name-style="western"><surname>Macleod</surname><given-names>U</given-names></name></person-group><article-title>Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review</article-title><source>Br J Cancer</source><year>2008</year><volume>98</volume><fpage>60</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">18059401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.bjc.6604096</pub-id><pub-id pub-id-type="pmcid">PMC2359711</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name><name name-style="western"><surname>Wen</surname><given-names>F</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Yi</surname><given-names>C</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Y</given-names></name></person-group><article-title>Young patients (&#8804; 35 years old) with colorectal cancer have worse outcomes due to more advanced disease: a 30-year retrospective review</article-title><source>Medicine (Baltimore)</source><year>2014</year><volume>93</volume><fpage>e135</fpage><pub-id pub-id-type="pmid">25415667</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000000135</pub-id><pub-id pub-id-type="pmcid">PMC4616343</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rho</surname><given-names>YS</given-names></name><name name-style="western"><surname>Gilabert</surname><given-names>M</given-names></name><name name-style="western"><surname>Polom</surname><given-names>K</given-names></name><name name-style="western"><surname>Aladashvili</surname><given-names>A</given-names></name><name name-style="western"><surname>Kopeckova</surname><given-names>K</given-names></name><name name-style="western"><surname>Megdanova</surname><given-names>V</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>N</given-names></name><name name-style="western"><surname>Greally</surname><given-names>M</given-names></name><name name-style="western"><surname>Marrelli</surname><given-names>D</given-names></name><name name-style="western"><surname>Roviello</surname><given-names>F</given-names></name><name name-style="western"><surname>McDermott</surname><given-names>R</given-names></name><name name-style="western"><surname>Petrova</surname><given-names>V</given-names></name><name name-style="western"><surname>Mihaylova</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bortlicek</surname><given-names>Z</given-names></name><name name-style="western"><surname>Prausova</surname><given-names>J</given-names></name><name name-style="western"><surname>Batist</surname><given-names>G</given-names></name><name name-style="western"><surname>Azoulay</surname><given-names>L</given-names></name><name name-style="western"><surname>Kavan</surname><given-names>P</given-names></name></person-group><article-title>Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study</article-title><source>Clin Colorectal Cancer</source><year>2017</year><volume>16</volume><fpage>334</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">28462853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clcc.2017.03.008</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>ER</given-names></name><name name-style="western"><surname>Hong</surname><given-names>SN</given-names></name><name name-style="western"><surname>Chang</surname><given-names>DK</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YH</given-names></name></person-group><article-title>Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study</article-title><source>Medicine (Baltimore)</source><year>2016</year><volume>95</volume><fpage>e3641</fpage><pub-id pub-id-type="pmid">27175682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000003641</pub-id><pub-id pub-id-type="pmcid">PMC4902524</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ping</surname><given-names>J</given-names></name></person-group><article-title>Clinicopathological Features and Survival Outcomes of Colorectal Cancer in Young Versus Elderly: A Population-Based Cohort Study of SEER 9 Registries Data (1988-2011)</article-title><source>Medicine (Baltimore)</source><year>2015</year><volume>94</volume><fpage>e1402</fpage><pub-id pub-id-type="pmid">26334895</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000001402</pub-id><pub-id pub-id-type="pmcid">PMC4616510</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silla</surname><given-names>IO</given-names></name><name name-style="western"><surname>Rueda</surname><given-names>D</given-names></name><name name-style="western"><surname>Rodr&#237;guez</surname><given-names>Y</given-names></name><name name-style="western"><surname>Garc&#237;a</surname><given-names>JL</given-names></name><name name-style="western"><surname>de</surname><given-names>la Cruz Vigo F</given-names></name><name name-style="western"><surname>Perea</surname><given-names>J</given-names></name></person-group><article-title>Early-onset colorectal cancer: a separate subset of colorectal cancer</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><fpage>17288</fpage><lpage>17296</lpage><pub-id pub-id-type="pmid">25516639</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v20.i46.17288</pub-id><pub-id pub-id-type="pmcid">PMC4265586</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yurgelun</surname><given-names>MB</given-names></name><name name-style="western"><surname>Kulke</surname><given-names>MH</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>CS</given-names></name><name name-style="western"><surname>Allen</surname><given-names>BA</given-names></name><name name-style="western"><surname>Uno</surname><given-names>H</given-names></name><name name-style="western"><surname>Hornick</surname><given-names>JL</given-names></name><name name-style="western"><surname>Ukaegbu</surname><given-names>CI</given-names></name><name name-style="western"><surname>Brais</surname><given-names>LK</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>PG</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Schrag</surname><given-names>D</given-names></name><name name-style="western"><surname>Meyerhardt</surname><given-names>JA</given-names></name><name name-style="western"><surname>Ng</surname><given-names>K</given-names></name><name name-style="western"><surname>Kidd</surname><given-names>J</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><name name-style="western"><surname>Hartman</surname><given-names>AR</given-names></name><name name-style="western"><surname>Wenstrup</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Syngal</surname><given-names>S</given-names></name></person-group><article-title>Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer</article-title><source>J Clin Oncol</source><year>2017</year><volume>35</volume><fpage>1086</fpage><lpage>1095</lpage><pub-id pub-id-type="pmid">28135145</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2016.71.0012</pub-id><pub-id pub-id-type="pmcid">PMC5455355</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearlman</surname><given-names>R</given-names></name><name name-style="western"><surname>Frankel</surname><given-names>WL</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name><name name-style="western"><surname>Yilmaz</surname><given-names>A</given-names></name><name name-style="western"><surname>Miller</surname><given-names>K</given-names></name><name name-style="western"><surname>Bacher</surname><given-names>J</given-names></name><name name-style="western"><surname>Bigley</surname><given-names>C</given-names></name><name name-style="western"><surname>Nelsen</surname><given-names>L</given-names></name><name name-style="western"><surname>Goodfellow</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>RM</given-names></name><name name-style="western"><surname>Paskett</surname><given-names>E</given-names></name><name name-style="western"><surname>Shields</surname><given-names>PG</given-names></name><name name-style="western"><surname>Freudenheim</surname><given-names>JL</given-names></name><name name-style="western"><surname>Stanich</surname><given-names>PP</given-names></name><name name-style="western"><surname>Lattimer</surname><given-names>I</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>M</given-names></name><name name-style="western"><surname>Liyanarachchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Kalady</surname><given-names>M</given-names></name><name name-style="western"><surname>Heald</surname><given-names>B</given-names></name><name name-style="western"><surname>Greenwood</surname><given-names>C</given-names></name><name name-style="western"><surname>Paquette</surname><given-names>I</given-names></name><name name-style="western"><surname>Prues</surname><given-names>M</given-names></name><name name-style="western"><surname>Draper</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Lindeman</surname><given-names>C</given-names></name><name name-style="western"><surname>Kuebler</surname><given-names>JP</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>K</given-names></name><name name-style="western"><surname>Brell</surname><given-names>JM</given-names></name><name name-style="western"><surname>Shaper</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mahesh</surname><given-names>S</given-names></name><name name-style="western"><surname>Buie</surname><given-names>N</given-names></name><name name-style="western"><surname>Weeman</surname><given-names>K</given-names></name><name name-style="western"><surname>Shine</surname><given-names>K</given-names></name><name name-style="western"><surname>Haut</surname><given-names>M</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>J</given-names></name><name name-style="western"><surname>Bastola</surname><given-names>S</given-names></name><name name-style="western"><surname>Wickham</surname><given-names>K</given-names></name><name name-style="western"><surname>Khanduja</surname><given-names>KS</given-names></name><name name-style="western"><surname>Zacks</surname><given-names>R</given-names></name><name name-style="western"><surname>Pritchard</surname><given-names>CC</given-names></name><name name-style="western"><surname>Shirts</surname><given-names>BH</given-names></name><name name-style="western"><surname>Jacobson</surname><given-names>A</given-names></name><name name-style="western"><surname>Allen</surname><given-names>B</given-names></name><name name-style="western"><surname>de</surname><given-names>la Chapelle A</given-names></name><name name-style="western"><surname>Hampel</surname><given-names>H</given-names></name></person-group><collab>Ohio Colorectal Cancer Prevention Initiative Study Group</collab><article-title>Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer</article-title><source>JAMA Oncol</source><year>2017</year><volume>3</volume><fpage>464</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">27978560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoncol.2016.5194</pub-id><pub-id pub-id-type="pmcid">PMC5564179</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puccini</surname><given-names>A</given-names></name><name name-style="western"><surname>Lenz</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>JL</given-names></name><name name-style="western"><surname>Arguello</surname><given-names>D</given-names></name><name name-style="western"><surname>Raghavan</surname><given-names>D</given-names></name><name name-style="western"><surname>Korn</surname><given-names>WM</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>BA</given-names></name><name name-style="western"><surname>Poorman</surname><given-names>K</given-names></name><name name-style="western"><surname>Heeke</surname><given-names>AL</given-names></name><name name-style="western"><surname>Philip</surname><given-names>PA</given-names></name><name name-style="western"><surname>Shields</surname><given-names>AF</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>RM</given-names></name><name name-style="western"><surname>Salem</surname><given-names>ME</given-names></name></person-group><article-title>Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors</article-title><source>Oncologist</source><year>2019</year><volume>24</volume><fpage>319</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">30018131</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1634/theoncologist.2018-0117</pub-id><pub-id pub-id-type="pmcid">PMC6519749</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Provenzale</surname><given-names>D</given-names></name><name name-style="western"><surname>Llor</surname><given-names>X</given-names></name><name name-style="western"><surname>Halverson</surname><given-names>AL</given-names></name><name name-style="western"><surname>Grady</surname><given-names>W</given-names></name><name name-style="western"><surname>Chung</surname><given-names>DC</given-names></name><name name-style="western"><surname>Haraldsdottir</surname><given-names>S</given-names></name><name name-style="western"><surname>Markowitz</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Slavin</surname><given-names>TP Jr</given-names></name><name name-style="western"><surname>Hampel</surname><given-names>H</given-names></name></person-group><collab>CGC, Ness RM, Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Mikkelson J</collab><collab> CGC, Peter S, Regenbogen SE, Dwyer MA</collab><collab> CGC, Ogba N</collab><article-title>NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019</article-title><source>J Natl Compr Canc Netw</source><year>2019</year><volume>17</volume><fpage>1032</fpage><lpage>1041</lpage></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Burke</surname><given-names>CA</given-names></name><name name-style="western"><surname>Axell</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>LM</given-names></name><name name-style="western"><surname>Chung</surname><given-names>DC</given-names></name><name name-style="western"><surname>Clayback</surname><given-names>KM</given-names></name><name name-style="western"><surname>Dallas</surname><given-names>S</given-names></name><name name-style="western"><surname>Felder</surname><given-names>S</given-names></name><name name-style="western"><surname>Gbolahan</surname><given-names>O</given-names></name><name name-style="western"><surname>Giardiello</surname><given-names>FM</given-names></name><name name-style="western"><surname>Grady</surname><given-names>W</given-names></name><name name-style="western"><surname>Hall</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Hampel</surname><given-names>H</given-names></name><name name-style="western"><surname>Hodan</surname><given-names>R</given-names></name><name name-style="western"><surname>Idos</surname><given-names>G</given-names></name><name name-style="western"><surname>Kanth</surname><given-names>P</given-names></name><name name-style="western"><surname>Katona</surname><given-names>B</given-names></name><name name-style="western"><surname>Lamps</surname><given-names>L</given-names></name><name name-style="western"><surname>Llor</surname><given-names>X</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>PM</given-names></name><name name-style="western"><surname>Markowitz</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Pirzadeh-Miller</surname><given-names>S</given-names></name><name name-style="western"><surname>Samadder</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>D</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Szymaniak</surname><given-names>BM</given-names></name><name name-style="western"><surname>Wiesner</surname><given-names>GL</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>A</given-names></name><name name-style="western"><surname>Yurgelun</surname><given-names>MB</given-names></name><name name-style="western"><surname>Zakhour</surname><given-names>M</given-names></name><name name-style="western"><surname>Darlow</surname><given-names>SD</given-names></name><name name-style="western"><surname>Dwyer</surname><given-names>MA</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>M</given-names></name></person-group><article-title>NCCN Guidelines&#174; Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021</article-title><source>J Natl Compr Canc Netw</source><year>2021</year><volume>19</volume><fpage>1122</fpage><lpage>1132</lpage><pub-id pub-id-type="pmid">34666312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/jnccn.2021.0048</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Currais</surname><given-names>P</given-names></name><name name-style="western"><surname>Rosa</surname><given-names>I</given-names></name><name name-style="western"><surname>Claro</surname><given-names>I</given-names></name></person-group><article-title>Colorectal cancer carcinogenesis: From bench to bedside</article-title><source>World J Gastrointest Oncol</source><year>2022</year><volume>14</volume><fpage>654</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">35321283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4251/wjgo.v14.i3.654</pub-id><pub-id pub-id-type="pmcid">PMC8919024</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Syngal</surname><given-names>S</given-names></name><name name-style="western"><surname>Brand</surname><given-names>RE</given-names></name><name name-style="western"><surname>Church</surname><given-names>JM</given-names></name><name name-style="western"><surname>Giardiello</surname><given-names>FM</given-names></name><name name-style="western"><surname>Hampel</surname><given-names>HL</given-names></name><name name-style="western"><surname>Burt</surname><given-names>RW</given-names></name></person-group><collab>American College of Gastroenterology</collab><article-title>ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes</article-title><source>Am J Gastroenterol</source><year>2015</year><volume>110</volume><fpage>223</fpage><lpage>62; quiz 263</lpage><pub-id pub-id-type="pmid">25645574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ajg.2014.435</pub-id><pub-id pub-id-type="pmcid">PMC4695986</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoffel</surname><given-names>EM</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>CC</given-names></name></person-group><article-title>Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults</article-title><source>Gastroenterology</source><year>2020</year><volume>158</volume><fpage>341</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">31394082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2019.07.055</pub-id><pub-id pub-id-type="pmcid">PMC6957715</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>FW</given-names></name><name name-style="western"><surname>Sundaram</surname><given-names>V</given-names></name><name name-style="western"><surname>Chew</surname><given-names>TA</given-names></name><name name-style="western"><surname>Ladabaum</surname><given-names>U</given-names></name></person-group><article-title>Low Prevalence of Criteria for Early Screening in Young-Onset Colorectal Cancer</article-title><source>Am J Prev Med</source><year>2017</year><volume>53</volume><fpage>933</fpage><lpage>934</lpage><pub-id pub-id-type="pmid">29051017</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2017.07.016</pub-id><pub-id pub-id-type="pmcid">PMC5873286</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andr&#233;</surname><given-names>T</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>R</given-names></name><name name-style="western"><surname>Salem</surname><given-names>ME</given-names></name></person-group><article-title>Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022</article-title><source>Am Soc Clin Oncol Educ Book</source><year>2022</year><volume>42</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/EDBK_349557</pub-id><pub-id pub-id-type="pmid">35471834</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banerjea</surname><given-names>A</given-names></name><name name-style="western"><surname>Hands</surname><given-names>RE</given-names></name><name name-style="western"><surname>Powar</surname><given-names>MP</given-names></name><name name-style="western"><surname>Bustin</surname><given-names>SA</given-names></name><name name-style="western"><surname>Dorudi</surname><given-names>S</given-names></name></person-group><article-title>Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence</article-title><source>Colorectal Dis</source><year>2009</year><volume>11</volume><fpage>601</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">18637931</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1463-1318.2008.01639.x</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>SA</given-names></name><name name-style="western"><surname>Morris</surname><given-names>M</given-names></name><name name-style="western"><surname>Idrees</surname><given-names>K</given-names></name><name name-style="western"><surname>Gimbel</surname><given-names>MI</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Gan</surname><given-names>G</given-names></name><name name-style="western"><surname>Shia</surname><given-names>J</given-names></name><name name-style="western"><surname>LaQuaglia</surname><given-names>MP</given-names></name><name name-style="western"><surname>Paty</surname><given-names>PB</given-names></name></person-group><article-title>Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients</article-title><source>J Pediatr Surg</source><year>2016</year><volume>51</volume><fpage>1812</fpage><lpage>1817</lpage><pub-id pub-id-type="pmid">27558481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpedsurg.2016.07.015</pub-id><pub-id pub-id-type="pmcid">PMC5312708</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antelo</surname><given-names>M</given-names></name><name name-style="western"><surname>Balaguer</surname><given-names>F</given-names></name><name name-style="western"><surname>Shia</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hur</surname><given-names>K</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>L</given-names></name><name name-style="western"><surname>Cuatrecasas</surname><given-names>M</given-names></name><name name-style="western"><surname>Bujanda</surname><given-names>L</given-names></name><name name-style="western"><surname>Giraldez</surname><given-names>MD</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Cabanne</surname><given-names>A</given-names></name><name name-style="western"><surname>Barugel</surname><given-names>ME</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>M</given-names></name><name name-style="western"><surname>Roca</surname><given-names>EL</given-names></name><name name-style="western"><surname>Andreu</surname><given-names>M</given-names></name><name name-style="western"><surname>Castellvi-Bel</surname><given-names>S</given-names></name><name name-style="western"><surname>Llor</surname><given-names>X</given-names></name><name name-style="western"><surname>Jover</surname><given-names>R</given-names></name><name name-style="western"><surname>Castells</surname><given-names>A</given-names></name><name name-style="western"><surname>Boland</surname><given-names>CR</given-names></name><name name-style="western"><surname>Goel</surname><given-names>A</given-names></name></person-group><article-title>A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e45357</fpage><pub-id pub-id-type="pmid">23049789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0045357</pub-id><pub-id pub-id-type="pmcid">PMC3458035</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yiu</surname><given-names>R</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Garc&#237;a-Aguilar</surname><given-names>J</given-names></name></person-group><article-title>Mechanisms of microsatellite instability in colorectal cancer patients in different age groups</article-title><source>Dis Colon Rectum</source><year>2005</year><volume>48</volume><fpage>2061</fpage><lpage>2069</lpage><pub-id pub-id-type="pmid">16374936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10350-005-0171-0</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Popat</surname><given-names>S</given-names></name><name name-style="western"><surname>Hubner</surname><given-names>R</given-names></name><name name-style="western"><surname>Houlston</surname><given-names>RS</given-names></name></person-group><article-title>Systematic review of microsatellite instability and colorectal cancer prognosis</article-title><source>J Clin Oncol</source><year>2005</year><volume>23</volume><fpage>609</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">15659508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2005.01.086</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perea</surname><given-names>J</given-names></name><name name-style="western"><surname>Rueda</surname><given-names>D</given-names></name><name name-style="western"><surname>Canal</surname><given-names>A</given-names></name><name name-style="western"><surname>Rodr&#237;guez</surname><given-names>Y</given-names></name><name name-style="western"><surname>&#193;lvaro</surname><given-names>E</given-names></name><name name-style="western"><surname>Osorio</surname><given-names>I</given-names></name><name name-style="western"><surname>Alegre</surname><given-names>C</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>B</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>J</given-names></name><name name-style="western"><surname>Ben&#237;tez</surname><given-names>J</given-names></name><name name-style="western"><surname>Urioste</surname><given-names>M</given-names></name></person-group><article-title>Age at onset should be a major criterion for subclassification of colorectal cancer</article-title><source>J Mol Diagn</source><year>2014</year><volume>16</volume><fpage>116</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">24184227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmoldx.2013.07.010</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballester</surname><given-names>V</given-names></name><name name-style="western"><surname>Rashtak</surname><given-names>S</given-names></name><name name-style="western"><surname>Boardman</surname><given-names>L</given-names></name></person-group><article-title>Clinical and molecular features of young-onset colorectal cancer</article-title><source>World J Gastroenterol</source><year>2016</year><volume>22</volume><fpage>1736</fpage><lpage>1744</lpage><pub-id pub-id-type="pmid">26855533</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v22.i5.1736</pub-id><pub-id pub-id-type="pmcid">PMC4724605</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>TL</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>LC</given-names></name><name name-style="western"><surname>Leung</surname><given-names>SY</given-names></name><name name-style="western"><surname>Farrington</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ho</surname><given-names>JW</given-names></name><name name-style="western"><surname>Chan</surname><given-names>AS</given-names></name><name name-style="western"><surname>Lam</surname><given-names>PW</given-names></name><name name-style="western"><surname>Tse</surname><given-names>CW</given-names></name><name name-style="western"><surname>Dunlop</surname><given-names>MG</given-names></name><name name-style="western"><surname>Wyllie</surname><given-names>AH</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>ST</given-names></name></person-group><article-title>Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes</article-title><source>Oncogene</source><year>2001</year><volume>20</volume><fpage>4871</fpage><lpage>4876</lpage><pub-id pub-id-type="pmid">11521198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.onc.1204653</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>PA</given-names></name><name name-style="western"><surname>Baylin</surname><given-names>SB</given-names></name></person-group><article-title>The epigenomics of cancer</article-title><source>Cell</source><year>2007</year><volume>128</volume><fpage>683</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">17320506</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2007.01.029</pub-id><pub-id pub-id-type="pmcid">PMC3894624</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogino</surname><given-names>S</given-names></name><name name-style="western"><surname>Nosho</surname><given-names>K</given-names></name><name name-style="western"><surname>Kirkner</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Kawasaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Chan</surname><given-names>AT</given-names></name><name name-style="western"><surname>Schernhammer</surname><given-names>ES</given-names></name><name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>CS</given-names></name></person-group><article-title>A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer</article-title><source>J Natl Cancer Inst</source><year>2008</year><volume>100</volume><fpage>1734</fpage><lpage>1738</lpage><pub-id pub-id-type="pmid">19033568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djn359</pub-id><pub-id pub-id-type="pmcid">PMC2639290</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herzig</surname><given-names>D</given-names></name><name name-style="western"><surname>Hardiman</surname><given-names>K</given-names></name><name name-style="western"><surname>Weiser</surname><given-names>M</given-names></name><name name-style="western"><surname>You</surname><given-names>N</given-names></name><name name-style="western"><surname>Paquette</surname><given-names>I</given-names></name><name name-style="western"><surname>Feingold</surname><given-names>DL</given-names></name><name name-style="western"><surname>Steele</surname><given-names>SR</given-names></name></person-group><article-title>The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes</article-title><source>Dis Colon Rectum</source><year>2017</year><volume>60</volume><fpage>881</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">28796726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/DCR.0000000000000912</pub-id><pub-id pub-id-type="pmcid">PMC5701653</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Argil&#233;s</surname><given-names>G</given-names></name><name name-style="western"><surname>Tabernero</surname><given-names>J</given-names></name><name name-style="western"><surname>Labianca</surname><given-names>R</given-names></name><name name-style="western"><surname>Hochhauser</surname><given-names>D</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>R</given-names></name><name name-style="western"><surname>Iveson</surname><given-names>T</given-names></name><name name-style="western"><surname>Laurent-Puig</surname><given-names>P</given-names></name><name name-style="western"><surname>Quirke</surname><given-names>P</given-names></name><name name-style="western"><surname>Yoshino</surname><given-names>T</given-names></name><name name-style="western"><surname>Taieb</surname><given-names>J</given-names></name><name name-style="western"><surname>Martinelli</surname><given-names>E</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>D</given-names></name></person-group><collab>ESMO Guidelines Committee</collab><article-title>Electronic address: clinicalguidelines@esmo.org. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</article-title><source>Ann Oncol</source><year>2020</year><volume>31</volume><fpage>1291</fpage><lpage>1305</lpage><pub-id pub-id-type="pmid">32702383</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.annonc.2020.06.022</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quah</surname><given-names>HM</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>R</given-names></name><name name-style="western"><surname>Schrag</surname><given-names>D</given-names></name><name name-style="western"><surname>Shia</surname><given-names>J</given-names></name><name name-style="western"><surname>Guillem</surname><given-names>JG</given-names></name><name name-style="western"><surname>Paty</surname><given-names>PB</given-names></name><name name-style="western"><surname>Temple</surname><given-names>LK</given-names></name><name name-style="western"><surname>Wong</surname><given-names>WD</given-names></name><name name-style="western"><surname>Weiser</surname><given-names>MR</given-names></name></person-group><article-title>Young age influences treatment but not outcome of colon cancer</article-title><source>Ann Surg Oncol</source><year>2007</year><volume>14</volume><fpage>2759</fpage><lpage>2765</lpage><pub-id pub-id-type="pmid">17593332</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1245/s10434-007-9465-x</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kneuertz</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Chang</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Hu</surname><given-names>CY</given-names></name><name name-style="western"><surname>Rodriguez-Bigas</surname><given-names>MA</given-names></name><name name-style="western"><surname>Eng</surname><given-names>C</given-names></name><name name-style="western"><surname>Vilar</surname><given-names>E</given-names></name><name name-style="western"><surname>Skibber</surname><given-names>JM</given-names></name><name name-style="western"><surname>Feig</surname><given-names>BW</given-names></name><name name-style="western"><surname>Cormier</surname><given-names>JN</given-names></name><name name-style="western"><surname>You</surname><given-names>YN</given-names></name></person-group><article-title>Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains</article-title><source>JAMA Surg</source><year>2015</year><volume>150</volume><fpage>402</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">25806815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2014.3572</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdelsattar</surname><given-names>ZM</given-names></name><name name-style="western"><surname>Wong</surname><given-names>SL</given-names></name><name name-style="western"><surname>Regenbogen</surname><given-names>SE</given-names></name><name name-style="western"><surname>Jomaa</surname><given-names>DM</given-names></name><name name-style="western"><surname>Hardiman</surname><given-names>KM</given-names></name><name name-style="western"><surname>Hendren</surname><given-names>S</given-names></name></person-group><article-title>Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening</article-title><source>Cancer</source><year>2016</year><volume>122</volume><fpage>929</fpage><lpage>934</lpage><pub-id pub-id-type="pmid">26808454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.29716</pub-id><pub-id pub-id-type="pmcid">PMC4777631</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van</surname><given-names>Erning FN</given-names></name><name name-style="western"><surname>van</surname><given-names>Steenbergen LN</given-names></name><name name-style="western"><surname>Lemmens</surname><given-names>VEPP</given-names></name><name name-style="western"><surname>Rutten</surname><given-names>HJT</given-names></name><name name-style="western"><surname>Martijn</surname><given-names>H</given-names></name><name name-style="western"><surname>van</surname><given-names>Spronsen DJ</given-names></name><name name-style="western"><surname>Janssen-Heijnen</surname><given-names>MLG</given-names></name></person-group><article-title>Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?</article-title><source>Eur J Cancer</source><year>2014</year><volume>50</volume><fpage>1731</fpage><lpage>1739</lpage><pub-id pub-id-type="pmid">24814358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2014.04.009</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D'Onofrio</surname><given-names>GM</given-names></name><name name-style="western"><surname>Tan</surname><given-names>EG</given-names></name></person-group><article-title>Is colorectal carcinoma in the young a more deadly disease?</article-title><source>Aust N Z J Surg</source><year>1985</year><volume>55</volume><fpage>537</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">3868989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1445-2197.1985.tb00940.x</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>YF</given-names></name><name name-style="western"><surname>Eu</surname><given-names>KW</given-names></name><name name-style="western"><surname>Machin</surname><given-names>D</given-names></name><name name-style="western"><surname>Ho</surname><given-names>JM</given-names></name><name name-style="western"><surname>Nyam</surname><given-names>DC</given-names></name><name name-style="western"><surname>Leong</surname><given-names>AF</given-names></name><name name-style="western"><surname>Ho</surname><given-names>YH</given-names></name><name name-style="western"><surname>Seow-Choen</surname><given-names>F</given-names></name></person-group><article-title>Young age is not a poor prognostic marker in colorectal cancer</article-title><source>Br J Surg</source><year>1998</year><volume>85</volume><fpage>1255</fpage><lpage>1259</lpage><pub-id pub-id-type="pmid">9752871</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2168.1998.00805.x</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varma</surname><given-names>JR</given-names></name><name name-style="western"><surname>Sample</surname><given-names>L</given-names></name></person-group><article-title>Colorectal cancer in patients aged less than 40 years</article-title><source>J Am Board Fam Pract</source><year>1990</year><volume>3</volume><fpage>54</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">2407049</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#252;low</surname><given-names>S</given-names></name></person-group><article-title>Colorectal cancer in patients less than 40 years of age in Denmark, 1943-1967</article-title><source>Dis Colon Rectum</source><year>1980</year><volume>23</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">7398507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02586840</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanke</surname><given-names>CD</given-names></name><name name-style="western"><surname>Bot</surname><given-names>BM</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>DM</given-names></name><name name-style="western"><surname>Bleyer</surname><given-names>A</given-names></name><name name-style="western"><surname>Kohne</surname><given-names>CH</given-names></name><name name-style="western"><surname>Seymour</surname><given-names>MT</given-names></name><name name-style="western"><surname>de</surname><given-names>Gramont A</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>RM</given-names></name><name name-style="western"><surname>Sargent</surname><given-names>DJ</given-names></name></person-group><article-title>Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials</article-title><source>J Clin Oncol</source><year>2011</year><volume>29</volume><fpage>2781</fpage><lpage>2786</lpage><pub-id pub-id-type="pmid">21646604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2010.33.5281</pub-id><pub-id pub-id-type="pmcid">PMC4874194</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Miller</surname><given-names>KD</given-names></name><name name-style="western"><surname>Fedewa</surname><given-names>SA</given-names></name><name name-style="western"><surname>Ahnen</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Meester</surname><given-names>RGS</given-names></name><name name-style="western"><surname>Barzi</surname><given-names>A</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Colorectal cancer statistics, 2017</article-title><source>CA Cancer J Clin</source><year>2017</year><volume>67</volume><fpage>177</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">28248415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21395</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sankila</surname><given-names>R</given-names></name><name name-style="western"><surname>Aaltonen</surname><given-names>LA</given-names></name><name name-style="western"><surname>J&#228;rvinen</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Mecklin</surname><given-names>JP</given-names></name></person-group><article-title>Better survival rates in patients with MLH1-associated hereditary colorectal cancer</article-title><source>Gastroenterology</source><year>1996</year><volume>110</volume><fpage>682</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">8608876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/gast.1996.v110.pm8608876</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watson</surname><given-names>P</given-names></name><name name-style="western"><surname>Lin</surname><given-names>KM</given-names></name><name name-style="western"><surname>Rodriguez-Bigas</surname><given-names>MA</given-names></name><name name-style="western"><surname>Smyrk</surname><given-names>T</given-names></name><name name-style="western"><surname>Lemon</surname><given-names>S</given-names></name><name name-style="western"><surname>Shashidharan</surname><given-names>M</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>B</given-names></name><name name-style="western"><surname>Karr</surname><given-names>B</given-names></name><name name-style="western"><surname>Thorson</surname><given-names>A</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>HT</given-names></name></person-group><article-title>Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members</article-title><source>Cancer</source><year>1998</year><volume>83</volume><fpage>259</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">9669808</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schreuders</surname><given-names>EH</given-names></name><name name-style="western"><surname>Ruco</surname><given-names>A</given-names></name><name name-style="western"><surname>Rabeneck</surname><given-names>L</given-names></name><name name-style="western"><surname>Schoen</surname><given-names>RE</given-names></name><name name-style="western"><surname>Sung</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Young</surname><given-names>GP</given-names></name><name name-style="western"><surname>Kuipers</surname><given-names>EJ</given-names></name></person-group><article-title>Colorectal cancer screening: a global overview of existing programmes</article-title><source>Gut</source><year>2015</year><volume>64</volume><fpage>1637</fpage><lpage>1649</lpage><pub-id pub-id-type="pmid">26041752</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2014-309086</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolf</surname><given-names>AMD</given-names></name><name name-style="western"><surname>Fontham</surname><given-names>ETH</given-names></name><name name-style="western"><surname>Church</surname><given-names>TR</given-names></name><name name-style="western"><surname>Flowers</surname><given-names>CR</given-names></name><name name-style="western"><surname>Guerra</surname><given-names>CE</given-names></name><name name-style="western"><surname>LaMonte</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Etzioni</surname><given-names>R</given-names></name><name name-style="western"><surname>McKenna</surname><given-names>MT</given-names></name><name name-style="western"><surname>Oeffinger</surname><given-names>KC</given-names></name><name name-style="western"><surname>Shih</surname><given-names>YT</given-names></name><name name-style="western"><surname>Walter</surname><given-names>LC</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>KS</given-names></name><name name-style="western"><surname>Brawley</surname><given-names>OW</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>D</given-names></name><name name-style="western"><surname>Fedewa</surname><given-names>SA</given-names></name><name name-style="western"><surname>Manassaram-Baptiste</surname><given-names>D</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Wender</surname><given-names>RC</given-names></name><name name-style="western"><surname>Smith</surname><given-names>RA</given-names></name></person-group><article-title>Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society</article-title><source>CA Cancer J Clin</source><year>2018</year><volume>68</volume><fpage>250</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">29846947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21457</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rundle</surname><given-names>AG</given-names></name><name name-style="western"><surname>Lebwohl</surname><given-names>B</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>R</given-names></name><name name-style="western"><surname>Levine</surname><given-names>S</given-names></name><name name-style="western"><surname>Neugut</surname><given-names>AI</given-names></name></person-group><article-title>Colonoscopic screening in average-risk individuals ages 40 to 49 <italic toggle="yes">vs</italic> 50 to 59 years</article-title><source>Gastroenterology</source><year>2008</year><volume>134</volume><fpage>1311</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">18471508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2008.02.032</pub-id><pub-id pub-id-type="pmcid">PMC3673301</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>You</surname><given-names>YN</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Y</given-names></name><name name-style="western"><surname>Feig</surname><given-names>BW</given-names></name><name name-style="western"><surname>Chang</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Cormier</surname><given-names>JN</given-names></name></person-group><article-title>Young-onset colorectal cancer: is it time to pay attention?</article-title><source>Arch Intern Med</source><year>2012</year><volume>172</volume><fpage>287</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">22157065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinternmed.2011.602</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>JC</given-names></name><name name-style="western"><surname>Samadder</surname><given-names>JN</given-names></name></person-group><article-title>To Screen or Not to Screen Adults 45-49 Years of Age: That is the Question</article-title><source>Am J Gastroenterol</source><year>2018</year><volume>113</volume><fpage>1750</fpage><lpage>1753</lpage><pub-id pub-id-type="pmid">30385833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41395-018-0402-3</pub-id><pub-id pub-id-type="pmcid">PMC6768580</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kastrinos</surname><given-names>F</given-names></name><name name-style="western"><surname>Steyerberg</surname><given-names>EW</given-names></name><name name-style="western"><surname>Mercado</surname><given-names>R</given-names></name><name name-style="western"><surname>Balma&#241;a</surname><given-names>J</given-names></name><name name-style="western"><surname>Holter</surname><given-names>S</given-names></name><name name-style="western"><surname>Gallinger</surname><given-names>S</given-names></name><name name-style="western"><surname>Siegmund</surname><given-names>KD</given-names></name><name name-style="western"><surname>Church</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>MA</given-names></name><name name-style="western"><surname>Lindor</surname><given-names>NM</given-names></name><name name-style="western"><surname>Thibodeau</surname><given-names>SN</given-names></name><name name-style="western"><surname>Burbidge</surname><given-names>LA</given-names></name><name name-style="western"><surname>Wenstrup</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Syngal</surname><given-names>S</given-names></name></person-group><article-title>The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history</article-title><source>Gastroenterology</source><year>2011</year><volume>140</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">20727894</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2010.08.021</pub-id><pub-id pub-id-type="pmcid">PMC3125673</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hendren</surname><given-names>SK</given-names></name><name name-style="western"><surname>O'Connor</surname><given-names>BI</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Asano</surname><given-names>T</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Swallow</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Macrae</surname><given-names>HM</given-names></name><name name-style="western"><surname>Gryfe</surname><given-names>R</given-names></name><name name-style="western"><surname>McLeod</surname><given-names>RS</given-names></name></person-group><article-title>Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer</article-title><source>Ann Surg</source><year>2005</year><volume>242</volume><fpage>212</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">16041212</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.sla.0000171299.43954.ce</pub-id><pub-id pub-id-type="pmcid">PMC1357727</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Schover</surname><given-names>LR</given-names></name><name name-style="western"><surname>Partridge</surname><given-names>AH</given-names></name><name name-style="western"><surname>Patrizio</surname><given-names>P</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>WH</given-names></name><name name-style="western"><surname>Hagerty</surname><given-names>K</given-names></name><name name-style="western"><surname>Beck</surname><given-names>LN</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>LV</given-names></name><name name-style="western"><surname>Oktay</surname><given-names>K</given-names></name></person-group><collab>American Society of Clinical Oncology</collab><article-title>American Society of Clinical Oncology recommendations on fertility preservation in cancer patients</article-title><source>J Clin Oncol</source><year>2006</year><volume>24</volume><fpage>2917</fpage><lpage>2931</lpage><pub-id pub-id-type="pmid">16651642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2006.06.5888</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oktay</surname><given-names>K</given-names></name><name name-style="western"><surname>Harvey</surname><given-names>BE</given-names></name><name name-style="western"><surname>Loren</surname><given-names>AW</given-names></name></person-group><article-title>Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update Summary</article-title><source>J Oncol Pract</source><year>2018</year><volume>14</volume><fpage>381</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">29768110</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JOP.18.00160</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>JE</given-names></name><name name-style="western"><surname>Dasari</surname><given-names>A</given-names></name><name name-style="western"><surname>Eng</surname><given-names>C</given-names></name></person-group><article-title>The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges</article-title><source>Oncologist</source><year>2016</year><volume>21</volume><fpage>563</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">27000464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1634/theoncologist.2015-0362</pub-id><pub-id pub-id-type="pmcid">PMC4861360</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reese</surname><given-names>JB</given-names></name><name name-style="western"><surname>Finan</surname><given-names>PH</given-names></name><name name-style="western"><surname>Haythornthwaite</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kadan</surname><given-names>M</given-names></name><name name-style="western"><surname>Regan</surname><given-names>KR</given-names></name><name name-style="western"><surname>Herman</surname><given-names>JM</given-names></name><name name-style="western"><surname>Efron</surname><given-names>J</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>LA Jr</given-names></name><name name-style="western"><surname>Azad</surname><given-names>NS</given-names></name></person-group><article-title>Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status</article-title><source>Support Care Cancer</source><year>2014</year><volume>22</volume><fpage>461</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">24091721</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00520-013-1998-x</pub-id><pub-id pub-id-type="pmcid">PMC3967444</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bailey</surname><given-names>CE</given-names></name><name name-style="western"><surname>Tran</surname><given-names>Cao HS</given-names></name><name name-style="western"><surname>Hu</surname><given-names>CY</given-names></name><name name-style="western"><surname>Chang</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Feig</surname><given-names>BW</given-names></name><name name-style="western"><surname>Rodriguez-Bigas</surname><given-names>MA</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>ST</given-names></name><name name-style="western"><surname>Skibber</surname><given-names>JM</given-names></name><name name-style="western"><surname>You</surname><given-names>YN</given-names></name></person-group><article-title>Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis</article-title><source>J Gastrointest Surg</source><year>2015</year><volume>19</volume><fpage>180</fpage><lpage>8; discussio 188</lpage><pub-id pub-id-type="pmid">25213581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11605-014-2645-7</pub-id><pub-id pub-id-type="pmcid">PMC4289079</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mols</surname><given-names>F</given-names></name><name name-style="western"><surname>Schoormans</surname><given-names>D</given-names></name><name name-style="western"><surname>de</surname><given-names>Hingh I</given-names></name><name name-style="western"><surname>Oerlemans</surname><given-names>S</given-names></name><name name-style="western"><surname>Husson</surname><given-names>O</given-names></name></person-group><article-title>Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life</article-title><source>Cancer</source><year>2018</year><volume>124</volume><fpage>2621</fpage><lpage>2628</lpage><pub-id pub-id-type="pmid">29624635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.31369</pub-id><pub-id pub-id-type="pmcid">PMC6033166</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>BL</given-names></name><name name-style="western"><surname>DeRubeis</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Berman</surname><given-names>BS</given-names></name><name name-style="western"><surname>Gruman</surname><given-names>J</given-names></name><name name-style="western"><surname>Champion</surname><given-names>VL</given-names></name><name name-style="western"><surname>Massie</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Holland</surname><given-names>JC</given-names></name><name name-style="western"><surname>Partridge</surname><given-names>AH</given-names></name><name name-style="western"><surname>Bak</surname><given-names>K</given-names></name><name name-style="western"><surname>Somerfield</surname><given-names>MR</given-names></name><name name-style="western"><surname>Rowland</surname><given-names>JH</given-names></name></person-group><collab>American Society of Clinical Oncology</collab><article-title>Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation</article-title><source>J Clin Oncol</source><year>2014</year><volume>32</volume><fpage>1605</fpage><lpage>1619</lpage><pub-id pub-id-type="pmid">24733793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.2013.52.4611</pub-id><pub-id pub-id-type="pmcid">PMC4090422</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>